id	sid	tid	token	lemma	pos
aiua-9216	1	1	stesura	stesura	PROPN
aiua-9216	1	2	seveso	seveso	PROPN
aiua-9216	1	3	archivio	archivio	PROPN
aiua-9216	1	4	italiano	italiano	X
aiua-9216	1	5	di	di	X
aiua-9216	1	6	urologia	urologia	PROPN
aiua-9216	1	7	e	e	PROPN
aiua-9216	1	8	andrologia	andrologia	NOUN
aiua-9216	1	9	2020	2020	NUM
aiua-9216	1	10	;	;	PUNCT
aiua-9216	1	11	92	92	NUM
aiua-9216	1	12	,	,	PUNCT
aiua-9216	1	13	4390	4390	NUM
aiua-9216	1	14	case	case	NOUN
aiua-9216	1	15	report	report	VERB
aiua-9216	1	16	no	no	DET
aiua-9216	1	17	conflict	conflict	NOUN
aiua-9216	1	18	of	of	ADP
aiua-9216	1	19	interest	interest	NOUN
aiua-9216	1	20	declared	declare	VERB
aiua-9216	1	21	.	.	PUNCT
aiua-9216	2	1	doi	doi	NOUN
aiua-9216	2	2	:	:	PUNCT
aiua-9216	2	3	10.4081	10.4081	NUM
aiua-9216	2	4	/	/	SYM
aiua-9216	2	5	aiua.2020.4.390	aiua.2020.4.390	NOUN
aiua-9216	2	6	primitive	primitive	ADJ
aiua-9216	2	7	small	small	ADJ
aiua-9216	2	8	cell	cell	NOUN
aiua-9216	2	9	carcinoma	carcinoma	NOUN
aiua-9216	2	10	of	of	ADP
aiua-9216	2	11	the	the	DET
aiua-9216	2	12	prostate	prostate	NOUN
aiua-9216	2	13	.	.	PUNCT
aiua-9216	3	1	case	case	NOUN
aiua-9216	3	2	report	report	NOUN
aiua-9216	3	3	and	and	CCONJ
aiua-9216	3	4	revision	revision	NOUN
aiua-9216	3	5	of	of	ADP
aiua-9216	3	6	the	the	DET
aiua-9216	3	7	literature	literature	PROPN
aiua-9216	3	8	pietro	pietro	PROPN
aiua-9216	3	9	pepe	pepe	PROPN
aiua-9216	3	10	1	1	NUM
aiua-9216	3	11	,	,	PUNCT
aiua-9216	3	12	ludovica	ludovica	PROPN
aiua-9216	3	13	pepe	pepe	PROPN
aiua-9216	3	14	1	1	NUM
aiua-9216	3	15	,	,	PUNCT
aiua-9216	3	16	mara	mara	PROPN
aiua-9216	3	17	curdman	curdman	PROPN
aiua-9216	3	18	2	2	NUM
aiua-9216	3	19	,	,	PUNCT
aiua-9216	3	20	michele	michele	PROPN
aiua-9216	3	21	pennisi	pennisi	VERB
aiua-9216	3	22	1	1	NUM
aiua-9216	3	23	,	,	PUNCT
aiua-9216	3	24	filippo	filippo	X
aiua-9216	3	25	fraggetta	fraggetta	VERB
aiua-9216	3	26	2	2	NUM
aiua-9216	3	27	1	1	NUM
aiua-9216	3	28	urology	urology	NOUN
aiua-9216	3	29	unit	unit	NOUN
aiua-9216	3	30	cannizzaro	cannizzaro	NOUN
aiua-9216	3	31	hospital	hospital	PROPN
aiua-9216	3	32	,	,	PUNCT
aiua-9216	3	33	catania	catania	PROPN
aiua-9216	3	34	,	,	PUNCT
aiua-9216	3	35	italy	italy	PROPN
aiua-9216	3	36	;	;	PUNCT
aiua-9216	3	37	2	2	NUM
aiua-9216	3	38	pathology	pathology	NOUN
aiua-9216	3	39	unit	unit	NOUN
aiua-9216	3	40	cannizzaro	cannizzaro	NOUN
aiua-9216	3	41	hospital	hospital	PROPN
aiua-9216	3	42	,	,	PUNCT
aiua-9216	3	43	catania	catania	PROPN
aiua-9216	3	44	,	,	PUNCT
aiua-9216	3	45	italy	italy	PROPN
aiua-9216	3	46	.	.	PUNCT
aiua-9216	4	1	inguinal	inguinal	ADJ
aiua-9216	4	2	hernia	hernia	NOUN
aiua-9216	4	3	repair	repair	NOUN
aiua-9216	4	4	.	.	PUNCT
aiua-9216	5	1	the	the	DET
aiua-9216	5	2	patient	patient	NOUN
aiua-9216	5	3	had	have	VERB
aiua-9216	5	4	not	not	PART
aiua-9216	5	5	familiarity	familiarity	NOUN
aiua-9216	5	6	for	for	ADP
aiua-9216	5	7	prostate	prostate	NOUN
aiua-9216	5	8	cancer	cancer	NOUN
aiua-9216	5	9	(	(	PUNCT
aiua-9216	5	10	pca	pca	PROPN
aiua-9216	5	11	)	)	PUNCT
aiua-9216	5	12	and	and	CCONJ
aiua-9216	5	13	assumed	assume	VERB
aiua-9216	5	14	antihypertensive	antihypertensive	ADJ
aiua-9216	5	15	and	and	CCONJ
aiua-9216	5	16	alfa	alfa	NOUN
aiua-9216	5	17	-	-	PUNCT
aiua-9216	5	18	blocker	blocker	NOUN
aiua-9216	5	19	drugs	drug	NOUN
aiua-9216	5	20	.	.	PUNCT
aiua-9216	6	1	at	at	ADP
aiua-9216	6	2	admission	admission	NOUN
aiua-9216	6	3	,	,	PUNCT
aiua-9216	6	4	the	the	DET
aiua-9216	6	5	patient	patient	NOUN
aiua-9216	6	6	referred	refer	VERB
aiua-9216	6	7	chronic	chronic	ADJ
aiua-9216	6	8	fatigue	fatigue	NOUN
aiua-9216	6	9	and	and	CCONJ
aiua-9216	6	10	was	be	AUX
aiua-9216	6	11	anuric	anuric	ADJ
aiua-9216	6	12	from	from	ADP
aiua-9216	6	13	two	two	NUM
aiua-9216	6	14	days	day	NOUN
aiua-9216	6	15	,	,	PUNCT
aiua-9216	6	16	serum	serum	NOUN
aiua-9216	6	17	creatinine	creatinine	NOUN
aiua-9216	6	18	and	and	CCONJ
aiua-9216	6	19	psa	psa	NOUN
aiua-9216	6	20	values	value	NOUN
aiua-9216	6	21	were	be	AUX
aiua-9216	6	22	equal	equal	ADJ
aiua-9216	6	23	to	to	ADP
aiua-9216	6	24	9.6	9.6	NUM
aiua-9216	6	25	mg	mg	PROPN
aiua-9216	6	26	/	/	SYM
aiua-9216	6	27	dl	dl	PROPN
aiua-9216	6	28	and	and	CCONJ
aiua-9216	6	29	4.8	4.8	NUM
aiua-9216	6	30	ng	ng	PROPN
aiua-9216	6	31	/	/	SYM
aiua-9216	6	32	ml	ml	PROPN
aiua-9216	6	33	,	,	PUNCT
aiua-9216	6	34	respectively	respectively	ADV
aiua-9216	6	35	;	;	PUNCT
aiua-9216	6	36	moreover	moreover	ADV
aiua-9216	6	37	,	,	PUNCT
aiua-9216	6	38	digital	digital	ADJ
aiua-9216	6	39	rectal	rectal	ADJ
aiua-9216	6	40	examination	examination	NOUN
aiua-9216	6	41	was	be	AUX
aiua-9216	6	42	highly	highly	ADV
aiua-9216	6	43	suspicious	suspicious	ADJ
aiua-9216	6	44	for	for	ADP
aiua-9216	6	45	pca	pca	PROPN
aiua-9216	6	46	.	.	PUNCT
aiua-9216	7	1	in	in	ADP
aiua-9216	7	2	emergency	emergency	NOUN
aiua-9216	7	3	,	,	PUNCT
aiua-9216	7	4	the	the	DET
aiua-9216	7	5	patient	patient	NOUN
aiua-9216	7	6	underwent	undergo	VERB
aiua-9216	7	7	bilateral	bilateral	ADJ
aiua-9216	7	8	application	application	NOUN
aiua-9216	7	9	of	of	ADP
aiua-9216	7	10	percutaneous	percutaneous	ADJ
aiua-9216	7	11	renal	renal	ADJ
aiua-9216	7	12	nephrostomies	nephrostomie	NOUN
aiua-9216	7	13	to	to	PART
aiua-9216	7	14	restore	restore	VERB
aiua-9216	7	15	kidney	kidney	NOUN
aiua-9216	7	16	function	function	NOUN
aiua-9216	7	17	.	.	PUNCT
aiua-9216	8	1	after	after	ADP
aiua-9216	8	2	three	three	NUM
aiua-9216	8	3	day	day	NOUN
aiua-9216	8	4	the	the	DET
aiua-9216	8	5	patient	patient	NOUN
aiua-9216	8	6	was	be	AUX
aiua-9216	8	7	submitted	submit	VERB
aiua-9216	8	8	to	to	ADP
aiua-9216	8	9	ultrasound	ultrasound	NOUN
aiua-9216	8	10	-	-	PUNCT
aiua-9216	8	11	guided	guide	VERB
aiua-9216	8	12	extended	extended	ADJ
aiua-9216	8	13	transperineal	transperineal	NOUN
aiua-9216	8	14	biopsy	biopsy	NOUN
aiua-9216	8	15	(	(	PUNCT
aiua-9216	8	16	6	6	NUM
aiua-9216	8	17	)	)	PUNCT
aiua-9216	8	18	;	;	PUNCT
aiua-9216	8	19	the	the	DET
aiua-9216	8	20	histology	histology	NOUN
aiua-9216	8	21	showed	show	VERB
aiua-9216	8	22	the	the	DET
aiua-9216	8	23	presence	presence	NOUN
aiua-9216	8	24	of	of	ADP
aiua-9216	8	25	a	a	DET
aiua-9216	8	26	prostatic	prostatic	ADJ
aiua-9216	8	27	scc	scc	NOUN
aiua-9216	8	28	fulfilling	fulfil	VERB
aiua-9216	8	29	the	the	DET
aiua-9216	8	30	world	world	NOUN
aiua-9216	8	31	health	health	NOUN
aiua-9216	8	32	organization	organization	NOUN
aiua-9216	8	33	criteria	criterion	NOUN
aiua-9216	8	34	that	that	PRON
aiua-9216	8	35	involved	involve	VERB
aiua-9216	8	36	all	all	DET
aiua-9216	8	37	the	the	DET
aiua-9216	8	38	12	12	NUM
aiua-9216	8	39	needle	needle	NOUN
aiua-9216	8	40	cores	core	NOUN
aiua-9216	8	41	(	(	PUNCT
aiua-9216	8	42	figure	figure	NOUN
aiua-9216	8	43	1	1	NUM
aiua-9216	8	44	)	)	PUNCT
aiua-9216	8	45	.	.	PUNCT
aiua-9216	9	1	the	the	DET
aiua-9216	9	2	immunohistochemical	immunohistochemical	ADJ
aiua-9216	9	3	analysis	analysis	NOUN
aiua-9216	9	4	was	be	AUX
aiua-9216	9	5	positive	positive	ADJ
aiua-9216	9	6	for	for	ADP
aiua-9216	9	7	chromogranin	chromogranin	NOUN
aiua-9216	9	8	,	,	PUNCT
aiua-9216	9	9	synaptophysin	synaptophysin	NOUN
aiua-9216	9	10	and	and	CCONJ
aiua-9216	9	11	focally	focally	ADV
aiua-9216	9	12	for	for	ADP
aiua-9216	9	13	thyroid	thyroid	NOUN
aiua-9216	9	14	transcriptation	transcriptation	NOUN
aiua-9216	9	15	factor	factor	NOUN
aiua-9216	9	16	1	1	NUM
aiua-9216	9	17	(	(	PUNCT
aiua-9216	9	18	ttf-1	ttf-1	NOUN
aiua-9216	9	19	)	)	PUNCT
aiua-9216	9	20	;	;	PUNCT
aiua-9216	9	21	ki67	ki67	PROPN
aiua-9216	9	22	expression	expression	NOUN
aiua-9216	9	23	was	be	AUX
aiua-9216	9	24	equal	equal	ADJ
aiua-9216	9	25	to	to	ADP
aiua-9216	9	26	85	85	NUM
aiua-9216	9	27	%	%	NOUN
aiua-9216	9	28	(	(	PUNCT
aiua-9216	9	29	figure	figure	NOUN
aiua-9216	9	30	2	2	NUM
aiua-9216	9	31	)	)	PUNCT
aiua-9216	9	32	,	,	PUNCT
aiua-9216	9	33	conversely	conversely	ADV
aiua-9216	9	34	,	,	PUNCT
aiua-9216	9	35	ck7	ck7	PROPN
aiua-9216	9	36	and	and	CCONJ
aiua-9216	9	37	p63	p63	NOUN
aiua-9216	9	38	were	be	AUX
aiua-9216	9	39	negative	negative	ADJ
aiua-9216	9	40	(	(	PUNCT
aiua-9216	9	41	7	7	NUM
aiua-9216	9	42	)	)	PUNCT
aiua-9216	9	43	.	.	PUNCT
aiua-9216	10	1	the	the	DET
aiua-9216	10	2	patient	patient	ADJ
aiua-9216	10	3	underwent	undergo	VERB
aiua-9216	10	4	clinical	clinical	ADJ
aiua-9216	10	5	staging	staging	NOUN
aiua-9216	10	6	including	include	VERB
aiua-9216	10	7	chest	chest	NOUN
aiua-9216	10	8	and	and	CCONJ
aiua-9216	10	9	abdominal	abdominal	ADJ
aiua-9216	10	10	computed	compute	VERB
aiua-9216	10	11	tomography	tomography	NOUN
aiua-9216	10	12	(	(	PUNCT
aiua-9216	10	13	ct	ct	PROPN
aiua-9216	10	14	)	)	PUNCT
aiua-9216	10	15	;	;	PUNCT
aiua-9216	10	16	evaluation	evaluation	NOUN
aiua-9216	10	17	and	and	CCONJ
aiua-9216	10	18	total	total	ADJ
aiua-9216	10	19	body	body	NOUN
aiua-9216	10	20	scan	scan	NOUN
aiua-9216	10	21	those	those	PRON
aiua-9216	10	22	did	do	AUX
aiua-9216	10	23	not	not	PART
aiua-9216	10	24	demonstrated	demonstrate	VERB
aiua-9216	10	25	distant	distant	ADJ
aiua-9216	10	26	metastases	metastasis	NOUN
aiua-9216	10	27	and/or	and/or	CCONJ
aiua-9216	10	28	others	other	NOUN
aiua-9216	10	29	primitive	primitive	ADJ
aiua-9216	10	30	tumors	tumor	NOUN
aiua-9216	10	31	;	;	PUNCT
aiua-9216	10	32	in	in	ADP
aiua-9216	10	33	addition	addition	NOUN
aiua-9216	10	34	,	,	PUNCT
aiua-9216	10	35	cystoscopy	cystoscopy	NOUN
aiua-9216	10	36	and	and	CCONJ
aiua-9216	10	37	urinary	urinary	ADJ
aiua-9216	10	38	cytology	cytology	NOUN
aiua-9216	10	39	were	be	AUX
aiua-9216	10	40	negative	negative	ADJ
aiua-9216	10	41	.	.	PUNCT
aiua-9216	11	1	the	the	DET
aiua-9216	11	2	patient	patient	ADJ
aiua-9216	11	3	underwent	undergo	VERB
aiua-9216	11	4	multidisciplinary	multidisciplinary	ADJ
aiua-9216	11	5	evaluation	evaluation	NOUN
aiua-9216	11	6	,	,	PUNCT
aiua-9216	11	7	but	but	CCONJ
aiua-9216	11	8	he	he	PRON
aiua-9216	11	9	died	die	VERB
aiua-9216	11	10	20	20	NUM
aiua-9216	11	11	days	day	NOUN
aiua-9216	11	12	from	from	ADP
aiua-9216	11	13	the	the	DET
aiua-9216	11	14	diagnosis	diagnosis	NOUN
aiua-9216	11	15	for	for	ADP
aiua-9216	11	16	progressive	progressive	ADJ
aiua-9216	11	17	clinical	clinical	ADJ
aiua-9216	11	18	worsening	worsen	VERB
aiua-9216	11	19	(	(	PUNCT
aiua-9216	11	20	physical	physical	ADJ
aiua-9216	11	21	and	and	CCONJ
aiua-9216	11	22	cognitive	cognitive	ADJ
aiua-9216	11	23	impairments	impairment	NOUN
aiua-9216	11	24	)	)	PUNCT
aiua-9216	11	25	before	before	ADP
aiua-9216	11	26	beginning	begin	VERB
aiua-9216	11	27	oncological	oncological	ADJ
aiua-9216	11	28	treatment	treatment	NOUN
aiua-9216	11	29	.	.	PUNCT
aiua-9216	12	1	autopsy	autopsy	ADJ
aiua-9216	12	2	was	be	AUX
aiua-9216	12	3	not	not	PART
aiua-9216	12	4	performed	perform	VERB
aiua-9216	12	5	.	.	PUNCT
aiua-9216	13	1	discussion	discussion	NOUN
aiua-9216	13	2	primitive	primitive	ADJ
aiua-9216	13	3	scc	scc	NOUN
aiua-9216	13	4	of	of	ADP
aiua-9216	13	5	the	the	DET
aiua-9216	13	6	prostate	prostate	NOUN
aiua-9216	13	7	is	be	AUX
aiua-9216	13	8	a	a	DET
aiua-9216	13	9	rare	rare	ADJ
aiua-9216	13	10	entity	entity	NOUN
aiua-9216	13	11	and	and	CCONJ
aiua-9216	13	12	has	have	VERB
aiua-9216	13	13	a	a	DET
aiua-9216	13	14	presentation	presentation	NOUN
aiua-9216	13	15	that	that	PRON
aiua-9216	13	16	is	be	AUX
aiua-9216	13	17	distinct	distinct	ADJ
aiua-9216	13	18	from	from	ADP
aiua-9216	13	19	its	its	PRON
aiua-9216	13	20	adenocarcinoma	adenocarcinoma	NOUN
aiua-9216	13	21	counterparts	counterpart	NOUN
aiua-9216	13	22	(	(	PUNCT
aiua-9216	13	23	8)	8)	NUM
aiua-9216	13	24	;	;	PUNCT
aiua-9216	13	25	unique	unique	ADJ
aiua-9216	13	26	features	feature	NOUN
aiua-9216	13	27	include	include	VERB
aiua-9216	13	28	an	an	DET
aiua-9216	13	29	unresponsiveness	unresponsiveness	NOUN
aiua-9216	13	30	to	to	ADP
aiua-9216	13	31	hormonal	hormonal	ADJ
aiua-9216	13	32	therapy	therapy	NOUN
aiua-9216	13	33	,	,	PUNCT
aiua-9216	13	34	rapid	rapid	ADJ
aiua-9216	13	35	progression	progression	NOUN
aiua-9216	13	36	,	,	PUNCT
aiua-9216	13	37	increased	increase	VERB
aiua-9216	13	38	risk	risk	NOUN
aiua-9216	13	39	of	of	ADP
aiua-9216	13	40	lytic	lytic	ADJ
aiua-9216	13	41	bone	bone	NOUN
aiua-9216	13	42	lesions	lesion	NOUN
aiua-9216	13	43	,	,	PUNCT
aiua-9216	13	44	presence	presence	NOUN
aiua-9216	13	45	of	of	ADP
aiua-9216	13	46	visceral	visceral	ADJ
aiua-9216	13	47	metastases	metastasis	NOUN
aiua-9216	13	48	,	,	PUNCT
aiua-9216	13	49	and	and	CCONJ
aiua-9216	13	50	low	low	ADJ
aiua-9216	13	51	psa	psa	NOUN
aiua-9216	13	52	in	in	ADP
aiua-9216	13	53	relation	relation	NOUN
aiua-9216	13	54	to	to	ADP
aiua-9216	13	55	disease	disease	NOUN
aiua-9216	13	56	burden	burden	NOUN
aiua-9216	13	57	.	.	PUNCT
aiua-9216	14	1	on	on	ADP
aiua-9216	14	2	the	the	DET
aiua-9216	14	3	other	other	ADJ
aiua-9216	14	4	hand	hand	NOUN
aiua-9216	14	5	,	,	PUNCT
aiua-9216	14	6	the	the	DET
aiua-9216	14	7	majority	majority	NOUN
aiua-9216	14	8	of	of	ADP
aiua-9216	14	9	prostate	prostate	NOUN
aiua-9216	14	10	scc	scc	PROPN
aiua-9216	14	11	are	be	AUX
aiua-9216	14	12	diagnosed	diagnose	VERB
aiua-9216	14	13	in	in	ADP
aiua-9216	14	14	men	man	NOUN
aiua-9216	14	15	with	with	ADP
aiua-9216	14	16	castration	castration	NOUN
aiua-9216	14	17	-	-	PUNCT
aiua-9216	14	18	resistant	resistant	ADJ
aiua-9216	14	19	prostate	prostate	NOUN
aiua-9216	14	20	cancer	cancer	NOUN
aiua-9216	14	21	(	(	PUNCT
aiua-9216	14	22	crpc	crpc	ADJ
aiua-9216	14	23	)	)	PUNCT
aiua-9216	14	24	and	and	CCONJ
aiua-9216	14	25	are	be	AUX
aiua-9216	14	26	often	often	ADV
aiua-9216	14	27	characterized	characterize	VERB
aiua-9216	14	28	by	by	ADP
aiua-9216	14	29	the	the	DET
aiua-9216	14	30	presence	presence	NOUN
aiua-9216	14	31	of	of	ADP
aiua-9216	14	32	neuroendocrine	neuroendocrine	NOUN
aiua-9216	14	33	(	(	PUNCT
aiua-9216	14	34	ne	ne	NOUN
aiua-9216	14	35	)	)	PUNCT
aiua-9216	14	36	cancer	cancer	NOUN
aiua-9216	14	37	differentiation	differentiation	NOUN
aiua-9216	14	38	.	.	PUNCT
aiua-9216	15	1	the	the	DET
aiua-9216	15	2	median	median	ADJ
aiua-9216	15	3	time	time	NOUN
aiua-9216	15	4	to	to	ADP
aiua-9216	15	5	development	development	NOUN
aiua-9216	15	6	of	of	ADP
aiua-9216	15	7	scc	scc	NOUN
aiua-9216	15	8	in	in	ADP
aiua-9216	15	9	patients	patient	NOUN
aiua-9216	15	10	with	with	ADP
aiua-9216	15	11	a	a	DET
aiua-9216	15	12	history	history	NOUN
aiua-9216	15	13	of	of	ADP
aiua-9216	15	14	prostatic	prostatic	ADJ
aiua-9216	15	15	adenocarcinoma	adenocarcinoma	NOUN
aiua-9216	15	16	is	be	AUX
aiua-9216	15	17	approximately	approximately	ADV
aiua-9216	15	18	18	18	NUM
aiua-9216	15	19	-	-	SYM
aiua-9216	15	20	24	24	NUM
aiua-9216	15	21	months	month	NOUN
aiua-9216	15	22	from	from	ADP
aiua-9216	15	23	diagnosis	diagnosis	NOUN
aiua-9216	15	24	,	,	PUNCT
aiua-9216	15	25	but	but	CCONJ
aiua-9216	15	26	ranges	range	VERB
aiua-9216	15	27	widely	widely	ADV
aiua-9216	15	28	from	from	ADP
aiua-9216	15	29	few	few	ADJ
aiua-9216	15	30	months	month	NOUN
aiua-9216	15	31	to	to	ADP
aiua-9216	15	32	several	several	ADJ
aiua-9216	15	33	years	year	NOUN
aiua-9216	15	34	.	.	PUNCT
aiua-9216	16	1	primitive	primitive	ADJ
aiua-9216	16	2	prostate	prostate	NOUN
aiua-9216	16	3	scc	scc	NOUN
aiua-9216	16	4	was	be	AUX
aiua-9216	16	5	first	first	ADV
aiua-9216	16	6	described	describe	VERB
aiua-9216	16	7	by	by	ADP
aiua-9216	16	8	wenk	wenk	PROPN
aiua-9216	16	9	et	et	PROPN
aiua-9216	16	10	al	al	PROPN
aiua-9216	16	11	.	.	PROPN
aiua-9216	17	1	(	(	PUNCT
aiua-9216	17	2	3	3	X
aiua-9216	17	3	)	)	PUNCT
aiua-9216	17	4	and	and	CCONJ
aiua-9216	17	5	,	,	PUNCT
aiua-9216	17	6	recently	recently	ADV
aiua-9216	17	7	,	,	PUNCT
aiua-9216	17	8	zhang	zhang	PROPN
aiua-9216	17	9	et	et	PROPN
aiua-9216	17	10	al	al	PROPN
aiua-9216	17	11	.	.	PROPN
aiua-9216	18	1	(	(	PUNCT
aiua-9216	18	2	4	4	X
aiua-9216	18	3	)	)	PUNCT
aiua-9216	18	4	reported	report	VERB
aiua-9216	18	5	8	8	NUM
aiua-9216	18	6	cases	case	NOUN
aiua-9216	18	7	of	of	ADP
aiua-9216	18	8	pure	pure	ADJ
aiua-9216	18	9	scc	scc	NOUN
aiua-9216	18	10	;	;	PUNCT
aiua-9216	18	11	autopsy	autopsy	ADJ
aiua-9216	18	12	studies	study	NOUN
aiua-9216	18	13	of	of	ADP
aiua-9216	18	14	men	man	NOUN
aiua-9216	18	15	who	who	PRON
aiua-9216	18	16	have	have	AUX
aiua-9216	18	17	died	die	VERB
aiua-9216	18	18	from	from	ADP
aiua-9216	18	19	crpc	crpc	PROPN
aiua-9216	18	20	a	a	DET
aiua-9216	18	21	caucasian	caucasian	ADJ
aiua-9216	18	22	man	man	NOUN
aiua-9216	18	23	84	84	NUM
aiua-9216	18	24	years	year	NOUN
aiua-9216	18	25	old	old	ADJ
aiua-9216	18	26	was	be	AUX
aiua-9216	18	27	admitted	admit	VERB
aiua-9216	18	28	to	to	ADP
aiua-9216	18	29	our	our	PRON
aiua-9216	18	30	department	department	NOUN
aiua-9216	18	31	for	for	ADP
aiua-9216	18	32	acute	acute	ADJ
aiua-9216	18	33	renal	renal	ADJ
aiua-9216	18	34	failure	failure	NOUN
aiua-9216	18	35	secondary	secondary	ADJ
aiua-9216	18	36	to	to	ADP
aiua-9216	18	37	severe	severe	ADJ
aiua-9216	18	38	bilateral	bilateral	ADJ
aiua-9216	18	39	hydronephrosis	hydronephrosis	NOUN
aiua-9216	18	40	;	;	PUNCT
aiua-9216	18	41	moreover	moreover	ADV
aiua-9216	18	42	,	,	PUNCT
aiua-9216	18	43	the	the	DET
aiua-9216	18	44	patient	patient	NOUN
aiua-9216	18	45	referred	refer	VERB
aiua-9216	18	46	chronic	chronic	ADJ
aiua-9216	18	47	fatigue	fatigue	NOUN
aiua-9216	18	48	and	and	CCONJ
aiua-9216	18	49	was	be	AUX
aiua-9216	18	50	anuric	anuric	ADJ
aiua-9216	18	51	from	from	ADP
aiua-9216	18	52	two	two	NUM
aiua-9216	18	53	days	day	NOUN
aiua-9216	18	54	.	.	PUNCT
aiua-9216	19	1	serum	serum	NOUN
aiua-9216	19	2	creatinine	creatinine	NOUN
aiua-9216	19	3	and	and	CCONJ
aiua-9216	19	4	psa	psa	NOUN
aiua-9216	19	5	values	value	NOUN
aiua-9216	19	6	were	be	AUX
aiua-9216	19	7	equal	equal	ADJ
aiua-9216	19	8	to	to	ADP
aiua-9216	19	9	9.6	9.6	NUM
aiua-9216	19	10	mg	mg	PROPN
aiua-9216	19	11	/	/	SYM
aiua-9216	19	12	dl	dl	PROPN
aiua-9216	19	13	and	and	CCONJ
aiua-9216	19	14	4.8	4.8	NUM
aiua-9216	19	15	ng	ng	PROPN
aiua-9216	19	16	/	/	SYM
aiua-9216	19	17	ml	ml	PROPN
aiua-9216	19	18	and	and	CCONJ
aiua-9216	19	19	digital	digital	ADJ
aiua-9216	19	20	rectal	rectal	ADJ
aiua-9216	19	21	examination	examination	NOUN
aiua-9216	19	22	was	be	AUX
aiua-9216	19	23	highly	highly	ADV
aiua-9216	19	24	suspicious	suspicious	ADJ
aiua-9216	19	25	for	for	ADP
aiua-9216	19	26	prostate	prostate	NOUN
aiua-9216	19	27	cancer	cancer	NOUN
aiua-9216	19	28	.	.	PUNCT
aiua-9216	20	1	in	in	ADP
aiua-9216	20	2	emergency	emergency	NOUN
aiua-9216	20	3	,	,	PUNCT
aiua-9216	20	4	the	the	DET
aiua-9216	20	5	patient	patient	NOUN
aiua-9216	20	6	underwent	undergo	VERB
aiua-9216	20	7	bilateral	bilateral	ADJ
aiua-9216	20	8	application	application	NOUN
aiua-9216	20	9	of	of	ADP
aiua-9216	20	10	percutaneous	percutaneous	ADJ
aiua-9216	20	11	renal	renal	ADJ
aiua-9216	20	12	nephrostomies	nephrostomie	NOUN
aiua-9216	20	13	to	to	PART
aiua-9216	20	14	restore	restore	VERB
aiua-9216	20	15	kidney	kidney	NOUN
aiua-9216	20	16	function	function	NOUN
aiua-9216	20	17	and	and	CCONJ
aiua-9216	20	18	,	,	PUNCT
aiua-9216	20	19	after	after	ADP
aiua-9216	20	20	three	three	NUM
aiua-9216	20	21	days	day	NOUN
aiua-9216	20	22	,	,	PUNCT
aiua-9216	20	23	was	be	AUX
aiua-9216	20	24	submitted	submit	VERB
aiua-9216	20	25	to	to	ADP
aiua-9216	20	26	ultrasound	ultrasound	NOUN
aiua-9216	20	27	-	-	PUNCT
aiua-9216	20	28	guided	guide	VERB
aiua-9216	20	29	extended	extended	ADJ
aiua-9216	20	30	transperineal	transperineal	NOUN
aiua-9216	20	31	biopsy	biopsy	NOUN
aiua-9216	20	32	;	;	PUNCT
aiua-9216	20	33	the	the	DET
aiua-9216	20	34	histology	histology	NOUN
aiua-9216	20	35	showed	show	VERB
aiua-9216	20	36	the	the	DET
aiua-9216	20	37	presence	presence	NOUN
aiua-9216	20	38	of	of	ADP
aiua-9216	20	39	a	a	DET
aiua-9216	20	40	prostatic	prostatic	ADJ
aiua-9216	20	41	small	small	ADJ
aiua-9216	20	42	cell	cell	NOUN
aiua-9216	20	43	carcinoma	carcinoma	NOUN
aiua-9216	20	44	(	(	PUNCT
aiua-9216	20	45	scc	scc	NOUN
aiua-9216	20	46	)	)	PUNCT
aiua-9216	20	47	fulfilling	fulfil	VERB
aiua-9216	20	48	the	the	DET
aiua-9216	20	49	world	world	NOUN
aiua-9216	20	50	health	health	PROPN
aiua-9216	20	51	organization	organization	NOUN
aiua-9216	20	52	criteria	criterion	NOUN
aiua-9216	20	53	.	.	PUNCT
aiua-9216	21	1	the	the	DET
aiua-9216	21	2	patient	patient	ADJ
aiua-9216	21	3	underwent	undergo	VERB
aiua-9216	21	4	clinical	clinical	ADJ
aiua-9216	21	5	staging	staging	NOUN
aiua-9216	21	6	including	include	VERB
aiua-9216	21	7	chest	chest	NOUN
aiua-9216	21	8	and	and	CCONJ
aiua-9216	21	9	abdominal	abdominal	ADJ
aiua-9216	21	10	computed	compute	VERB
aiua-9216	21	11	tomography	tomography	NOUN
aiua-9216	21	12	evaluation	evaluation	NOUN
aiua-9216	21	13	and	and	CCONJ
aiua-9216	21	14	total	total	ADJ
aiua-9216	21	15	body	body	NOUN
aiua-9216	21	16	scan	scan	NOUN
aiua-9216	21	17	that	that	PRON
aiua-9216	21	18	did	do	AUX
aiua-9216	21	19	not	not	PART
aiua-9216	21	20	demonstrated	demonstrate	VERB
aiua-9216	21	21	distant	distant	ADJ
aiua-9216	21	22	metastases	metastasis	NOUN
aiua-9216	21	23	and/or	and/or	CCONJ
aiua-9216	21	24	others	other	NOUN
aiua-9216	21	25	primitive	primitive	ADJ
aiua-9216	21	26	tumors	tumor	NOUN
aiua-9216	21	27	;	;	PUNCT
aiua-9216	21	28	in	in	ADP
aiua-9216	21	29	addition	addition	NOUN
aiua-9216	21	30	,	,	PUNCT
aiua-9216	21	31	cystoscopy	cystoscopy	NOUN
aiua-9216	21	32	and	and	CCONJ
aiua-9216	21	33	urinary	urinary	ADJ
aiua-9216	21	34	cytology	cytology	NOUN
aiua-9216	21	35	were	be	AUX
aiua-9216	21	36	negative	negative	ADJ
aiua-9216	21	37	.	.	PUNCT
aiua-9216	22	1	the	the	DET
aiua-9216	22	2	patient	patient	ADJ
aiua-9216	22	3	underwent	undergo	VERB
aiua-9216	22	4	multidisciplinary	multidisciplinary	ADJ
aiua-9216	22	5	evaluation	evaluation	NOUN
aiua-9216	22	6	,	,	PUNCT
aiua-9216	22	7	but	but	CCONJ
aiua-9216	22	8	he	he	PRON
aiua-9216	22	9	died	die	VERB
aiua-9216	22	10	20	20	NUM
aiua-9216	22	11	days	day	NOUN
aiua-9216	22	12	from	from	ADP
aiua-9216	22	13	the	the	DET
aiua-9216	22	14	diagnosis	diagnosis	NOUN
aiua-9216	22	15	for	for	ADP
aiua-9216	22	16	progressive	progressive	ADJ
aiua-9216	22	17	clinical	clinical	ADJ
aiua-9216	22	18	worsening	worsen	VERB
aiua-9216	22	19	(	(	PUNCT
aiua-9216	22	20	physical	physical	ADJ
aiua-9216	22	21	and	and	CCONJ
aiua-9216	22	22	cognitive	cognitive	ADJ
aiua-9216	22	23	impairments	impairment	NOUN
aiua-9216	22	24	)	)	PUNCT
aiua-9216	22	25	before	before	ADP
aiua-9216	22	26	beginning	begin	VERB
aiua-9216	22	27	oncological	oncological	ADJ
aiua-9216	22	28	treatment	treatment	NOUN
aiua-9216	22	29	.	.	PUNCT
aiua-9216	23	1	in	in	ADP
aiua-9216	23	2	conclusion	conclusion	NOUN
aiua-9216	23	3	,	,	PUNCT
aiua-9216	23	4	primitive	primitive	ADJ
aiua-9216	23	5	scc	scc	NOUN
aiua-9216	23	6	represents	represent	VERB
aiua-9216	23	7	a	a	DET
aiua-9216	23	8	very	very	ADV
aiua-9216	23	9	rare	rare	ADJ
aiua-9216	23	10	cancer	cancer	NOUN
aiua-9216	23	11	provided	provide	VERB
aiua-9216	23	12	of	of	ADP
aiua-9216	23	13	poor	poor	ADJ
aiua-9216	23	14	prognosis	prognosis	NOUN
aiua-9216	23	15	;	;	PUNCT
aiua-9216	23	16	only	only	ADV
aiua-9216	23	17	the	the	DET
aiua-9216	23	18	execution	execution	NOUN
aiua-9216	23	19	of	of	ADP
aiua-9216	23	20	prostate	prostate	NOUN
aiua-9216	23	21	biopsy	biopsy	NOUN
aiua-9216	23	22	combined	combine	VERB
aiua-9216	23	23	with	with	ADP
aiua-9216	23	24	an	an	DET
aiua-9216	23	25	accurate	accurate	ADJ
aiua-9216	23	26	specimen	speciman	NOUN
aiua-9216	23	27	analysis	analysis	NOUN
aiua-9216	23	28	allow	allow	VERB
aiua-9216	23	29	to	to	PART
aiua-9216	23	30	make	make	VERB
aiua-9216	23	31	the	the	DET
aiua-9216	23	32	correct	correct	ADJ
aiua-9216	23	33	diagnosis	diagnosis	NOUN
aiua-9216	23	34	and	and	CCONJ
aiua-9216	23	35	therapeutic	therapeutic	ADJ
aiua-9216	23	36	treatment	treatment	NOUN
aiua-9216	23	37	.	.	PUNCT
aiua-9216	24	1	key	key	ADJ
aiua-9216	24	2	words	word	NOUN
aiua-9216	24	3	:	:	PUNCT
aiua-9216	24	4	prostate	prostate	NOUN
aiua-9216	24	5	cancer	cancer	NOUN
aiua-9216	24	6	;	;	PUNCT
aiua-9216	24	7	small	small	ADJ
aiua-9216	24	8	cell	cell	NOUN
aiua-9216	24	9	cancer	cancer	NOUN
aiua-9216	24	10	;	;	PUNCT
aiua-9216	24	11	prostate	prostate	NOUN
aiua-9216	24	12	small	small	ADJ
aiua-9216	24	13	cell	cell	NOUN
aiua-9216	24	14	cancer	cancer	NOUN
aiua-9216	24	15	;	;	PUNCT
aiua-9216	24	16	neuroendocrine	neuroendocrine	ADJ
aiua-9216	24	17	small	small	ADJ
aiua-9216	24	18	cell	cell	NOUN
aiua-9216	24	19	prostate	prostate	NOUN
aiua-9216	24	20	cancer	cancer	NOUN
aiua-9216	24	21	.	.	PUNCT
aiua-9216	24	22	submitted	submit	VERB
aiua-9216	24	23	17	17	NUM
aiua-9216	24	24	july	july	PROPN
aiua-9216	24	25	2020	2020	NUM
aiua-9216	24	26	;	;	PUNCT
aiua-9216	24	27	accepted	accept	VERB
aiua-9216	24	28	30	30	NUM
aiua-9216	24	29	september	september	PROPN
aiua-9216	24	30	2020	2020	NUM
aiua-9216	24	31	introduction	introduction	NOUN
aiua-9216	24	32	primitive	primitive	ADJ
aiua-9216	24	33	small	small	ADJ
aiua-9216	24	34	cell	cell	NOUN
aiua-9216	24	35	carcinoma	carcinoma	NOUN
aiua-9216	24	36	(	(	PUNCT
aiua-9216	24	37	scc	scc	NOUN
aiua-9216	24	38	)	)	PUNCT
aiua-9216	24	39	of	of	ADP
aiua-9216	24	40	the	the	DET
aiua-9216	24	41	prostate	prostate	NOUN
aiua-9216	24	42	is	be	AUX
aiua-9216	24	43	a	a	DET
aiua-9216	24	44	very	very	ADV
aiua-9216	24	45	rare	rare	ADJ
aiua-9216	24	46	(	(	PUNCT
aiua-9216	24	47	0.5	0.5	NUM
aiua-9216	24	48	%	%	NOUN
aiua-9216	24	49	of	of	ADP
aiua-9216	24	50	the	the	DET
aiua-9216	24	51	cases	case	NOUN
aiua-9216	24	52	)	)	PUNCT
aiua-9216	24	53	and	and	CCONJ
aiua-9216	24	54	aggressive	aggressive	ADJ
aiua-9216	24	55	type	type	NOUN
aiua-9216	24	56	of	of	ADP
aiua-9216	24	57	prostatic	prostatic	ADJ
aiua-9216	24	58	cancer	cancer	NOUN
aiua-9216	24	59	and	and	CCONJ
aiua-9216	24	60	often	often	ADV
aiua-9216	24	61	is	be	AUX
aiua-9216	24	62	diagnosed	diagnose	VERB
aiua-9216	24	63	at	at	ADP
aiua-9216	24	64	advanced	advanced	ADJ
aiua-9216	24	65	stage	stage	NOUN
aiua-9216	24	66	due	due	ADP
aiua-9216	24	67	to	to	ADP
aiua-9216	24	68	early	early	ADJ
aiua-9216	24	69	metastasis	metastasis	NOUN
aiua-9216	24	70	(	(	PUNCT
aiua-9216	24	71	1	1	NUM
aiua-9216	24	72	-	-	SYM
aiua-9216	24	73	5	5	NUM
aiua-9216	24	74	)	)	PUNCT
aiua-9216	24	75	;	;	PUNCT
aiua-9216	24	76	most	most	ADV
aiua-9216	24	77	frequently	frequently	ADV
aiua-9216	24	78	,	,	PUNCT
aiua-9216	24	79	scc	scc	PROPN
aiua-9216	24	80	is	be	AUX
aiua-9216	24	81	associated	associate	VERB
aiua-9216	24	82	to	to	ADP
aiua-9216	24	83	progressive	progressive	ADJ
aiua-9216	24	84	hormone	hormone	NOUN
aiua-9216	24	85	-	-	PUNCT
aiua-9216	24	86	refractory	refractory	NOUN
aiua-9216	24	87	prostate	prostate	NOUN
aiua-9216	24	88	cancer	cancer	NOUN
aiua-9216	24	89	.	.	PUNCT
aiua-9216	25	1	the	the	DET
aiua-9216	25	2	biology	biology	NOUN
aiua-9216	25	3	of	of	ADP
aiua-9216	25	4	scc	scc	NOUN
aiua-9216	25	5	is	be	AUX
aiua-9216	25	6	poorly	poorly	ADV
aiua-9216	25	7	understood	understand	VERB
aiua-9216	25	8	but	but	CCONJ
aiua-9216	25	9	it	it	PRON
aiua-9216	25	10	is	be	AUX
aiua-9216	25	11	always	always	ADV
aiua-9216	25	12	implicated	implicate	VERB
aiua-9216	25	13	in	in	ADP
aiua-9216	25	14	the	the	DET
aiua-9216	25	15	lethal	lethal	ADJ
aiua-9216	25	16	progression	progression	NOUN
aiua-9216	25	17	secondary	secondary	ADJ
aiua-9216	25	18	to	to	ADP
aiua-9216	25	19	visceral	visceral	ADJ
aiua-9216	25	20	metastases	metastasis	NOUN
aiua-9216	25	21	and	and	CCONJ
aiua-9216	25	22	lytic	lytic	ADJ
aiua-9216	25	23	bones	bone	NOUN
aiua-9216	25	24	lesions	lesion	NOUN
aiua-9216	25	25	.	.	PUNCT
aiua-9216	26	1	in	in	ADP
aiua-9216	26	2	this	this	DET
aiua-9216	26	3	study	study	NOUN
aiua-9216	26	4	,	,	PUNCT
aiua-9216	26	5	a	a	DET
aiua-9216	26	6	case	case	NOUN
aiua-9216	26	7	of	of	ADP
aiua-9216	26	8	primitive	primitive	ADJ
aiua-9216	26	9	prostate	prostate	NOUN
aiua-9216	26	10	scc	scc	NOUN
aiua-9216	26	11	has	have	AUX
aiua-9216	26	12	been	be	AUX
aiua-9216	26	13	reported	report	VERB
aiua-9216	26	14	.	.	PUNCT
aiua-9216	27	1	case	case	NOUN
aiua-9216	27	2	report	report	VERB
aiua-9216	27	3	a	a	DET
aiua-9216	27	4	caucasian	caucasian	ADJ
aiua-9216	27	5	84	84	NUM
aiua-9216	27	6	years	year	NOUN
aiua-9216	27	7	old	old	ADJ
aiua-9216	27	8	man	man	NOUN
aiua-9216	27	9	was	be	AUX
aiua-9216	27	10	admitted	admit	VERB
aiua-9216	27	11	to	to	ADP
aiua-9216	27	12	our	our	PRON
aiua-9216	27	13	department	department	NOUN
aiua-9216	27	14	for	for	ADP
aiua-9216	27	15	acute	acute	ADJ
aiua-9216	27	16	renal	renal	ADJ
aiua-9216	27	17	failure	failure	NOUN
aiua-9216	27	18	secondary	secondary	ADJ
aiua-9216	27	19	to	to	ADP
aiua-9216	27	20	severe	severe	ADJ
aiua-9216	27	21	bilateral	bilateral	ADJ
aiua-9216	27	22	hydronephrosis	hydronephrosis	NOUN
aiua-9216	27	23	;	;	PUNCT
aiua-9216	27	24	the	the	DET
aiua-9216	27	25	patient	patient	NOUN
aiua-9216	27	26	suffered	suffer	VERB
aiua-9216	27	27	from	from	ADP
aiua-9216	27	28	blood	blood	NOUN
aiua-9216	27	29	hypertension	hypertension	NOUN
aiua-9216	27	30	and	and	CCONJ
aiua-9216	27	31	was	be	AUX
aiua-9216	27	32	previously	previously	ADV
aiua-9216	27	33	submitted	submit	VERB
aiua-9216	27	34	to	to	ADP
aiua-9216	27	35	right	right	ADJ
aiua-9216	27	36	summary	summary	NOUN
aiua-9216	27	37	391archivio	391archivio	PROPN
aiua-9216	27	38	italiano	italiano	NOUN
aiua-9216	27	39	di	di	X
aiua-9216	27	40	urologia	urologia	PROPN
aiua-9216	27	41	e	e	PROPN
aiua-9216	27	42	andrologia	andrologia	NOUN
aiua-9216	27	43	2020	2020	NUM
aiua-9216	27	44	;	;	PUNCT
aiua-9216	27	45	92	92	NUM
aiua-9216	27	46	,	,	PUNCT
aiua-9216	27	47	4	4	NUM
aiua-9216	27	48	primitive	primitive	ADJ
aiua-9216	27	49	small	small	ADJ
aiua-9216	27	50	cell	cell	NOUN
aiua-9216	27	51	carcinoma	carcinoma	NOUN
aiua-9216	27	52	of	of	ADP
aiua-9216	27	53	the	the	DET
aiua-9216	27	54	prostate	prostate	NOUN
aiua-9216	27	55	have	have	AUX
aiua-9216	27	56	reported	report	VERB
aiua-9216	27	57	the	the	DET
aiua-9216	27	58	presence	presence	NOUN
aiua-9216	27	59	of	of	ADP
aiua-9216	27	60	scc	scc	NOUN
aiua-9216	27	61	in	in	ADP
aiua-9216	27	62	up	up	ADV
aiua-9216	27	63	10	10	NUM
aiua-9216	27	64	-	-	SYM
aiua-9216	27	65	20	20	NUM
aiua-9216	27	66	%	%	NOUN
aiua-9216	27	67	of	of	ADP
aiua-9216	27	68	cases	case	NOUN
aiua-9216	27	69	.	.	PUNCT
aiua-9216	28	1	the	the	DET
aiua-9216	28	2	histological	histological	ADJ
aiua-9216	28	3	diagnosis	diagnosis	NOUN
aiua-9216	28	4	of	of	ADP
aiua-9216	28	5	scc	scc	NOUN
aiua-9216	28	6	is	be	AUX
aiua-9216	28	7	reached	reach	VERB
aiua-9216	28	8	based	base	VERB
aiua-9216	28	9	on	on	ADP
aiua-9216	28	10	the	the	DET
aiua-9216	28	11	presence	presence	NOUN
aiua-9216	28	12	of	of	ADP
aiua-9216	28	13	morphological	morphological	ADJ
aiua-9216	28	14	features	feature	NOUN
aiua-9216	28	15	similar	similar	ADJ
aiua-9216	28	16	to	to	ADP
aiua-9216	28	17	those	those	PRON
aiua-9216	28	18	found	find	VERB
aiua-9216	28	19	in	in	ADP
aiua-9216	28	20	scc	scc	NOUN
aiua-9216	28	21	of	of	ADP
aiua-9216	28	22	the	the	DET
aiua-9216	28	23	lung	lung	NOUN
aiua-9216	28	24	;	;	PUNCT
aiua-9216	28	25	using	use	VERB
aiua-9216	28	26	immunohistochemical	immunohistochemical	ADJ
aiua-9216	28	27	techniques	technique	NOUN
aiua-9216	28	28	,	,	PUNCT
aiua-9216	28	29	the	the	DET
aiua-9216	28	30	small	small	ADJ
aiua-9216	28	31	-	-	PUNCT
aiua-9216	28	32	cell	cell	NOUN
aiua-9216	28	33	component	component	NOUN
aiua-9216	28	34	could	could	AUX
aiua-9216	28	35	be	be	AUX
aiua-9216	28	36	positive	positive	ADJ
aiua-9216	28	37	for	for	ADP
aiua-9216	28	38	one	one	NUM
aiua-9216	28	39	or	or	CCONJ
aiua-9216	28	40	more	more	ADJ
aiua-9216	28	41	neuroendocrine	neuroendocrine	ADJ
aiua-9216	28	42	markers	marker	NOUN
aiua-9216	28	43	(	(	PUNCT
aiua-9216	28	44	i.e.	i.e.	X
aiua-9216	28	45	,	,	PUNCT
aiua-9216	28	46	neuron	neuron	NOUN
aiua-9216	28	47	-	-	PUNCT
aiua-9216	28	48	specific	specific	ADJ
aiua-9216	28	49	enolase	enolase	NOUN
aiua-9216	28	50	,	,	PUNCT
aiua-9216	28	51	synapthosiphysin	synapthosiphysin	NOUN
aiua-9216	28	52	,	,	PUNCT
aiua-9216	28	53	chromogranin	chromogranin	ADJ
aiua-9216	28	54	,	,	PUNCT
aiua-9216	28	55	and	and	CCONJ
aiua-9216	28	56	cd56	cd56	PROPN
aiua-9216	28	57	)	)	PUNCT
aiua-9216	28	58	in	in	ADP
aiua-9216	28	59	almost	almost	ADV
aiua-9216	28	60	90	90	NUM
aiua-9216	28	61	%	%	NOUN
aiua-9216	28	62	of	of	ADP
aiua-9216	28	63	the	the	DET
aiua-9216	28	64	cases	case	NOUN
aiua-9216	28	65	.	.	PUNCT
aiua-9216	29	1	studies	study	NOUN
aiua-9216	29	2	have	have	AUX
aiua-9216	29	3	demonstrated	demonstrate	VERB
aiua-9216	29	4	thyroid	thyroid	NOUN
aiua-9216	29	5	transcriptation	transcriptation	NOUN
aiua-9216	29	6	factor	factor	NOUN
aiua-9216	29	7	1	1	NUM
aiua-9216	29	8	(	(	PUNCT
aiua-9216	29	9	tyf-1	tyf-1	NUM
aiua-9216	29	10	)	)	PUNCT
aiua-9216	29	11	expression	expression	NOUN
aiua-9216	29	12	in	in	ADP
aiua-9216	29	13	over	over	ADP
aiua-9216	29	14	50	50	NUM
aiua-9216	29	15	%	%	NOUN
aiua-9216	29	16	of	of	ADP
aiua-9216	29	17	sccs	sccs	NOUN
aiua-9216	29	18	of	of	ADP
aiua-9216	29	19	the	the	DET
aiua-9216	29	20	prostate	prostate	NOUN
aiua-9216	29	21	,	,	PUNCT
aiua-9216	29	22	85	85	NUM
aiua-9216	29	23	-	-	SYM
aiua-9216	29	24	90	90	NUM
aiua-9216	29	25	%	%	NOUN
aiua-9216	29	26	loss	loss	NOUN
aiua-9216	29	27	rate	rate	NOUN
aiua-9216	29	28	of	of	ADP
aiua-9216	29	29	tumor	tumor	NOUN
aiua-9216	29	30	suppressor	suppressor	NOUN
aiua-9216	29	31	retinoblastoma	retinoblastoma	NOUN
aiua-9216	29	32	protein	protein	NOUN
aiua-9216	29	33	(	(	PUNCT
aiua-9216	29	34	rb1	rb1	PROPN
aiua-9216	29	35	)	)	PUNCT
aiua-9216	29	36	,	,	PUNCT
aiua-9216	29	37	and	and	CCONJ
aiua-9216	29	38	50	50	NUM
aiua-9216	29	39	-	-	SYM
aiua-9216	29	40	60	60	NUM
aiua-9216	29	41	%	%	NOUN
aiua-9216	29	42	mutation	mutation	NOUN
aiua-9216	29	43	rate	rate	NOUN
aiua-9216	29	44	of	of	ADP
aiua-9216	29	45	tp53	tp53	PROPN
aiua-9216	29	46	,	,	PUNCT
aiua-9216	29	47	limiting	limit	VERB
aiua-9216	29	48	its	its	PRON
aiua-9216	29	49	utility	utility	NOUN
aiua-9216	29	50	in	in	ADP
aiua-9216	29	51	distinguishing	distinguish	VERB
aiua-9216	29	52	primary	primary	ADJ
aiua-9216	29	53	prostate	prostate	NOUN
aiua-9216	29	54	scc	scc	NOUN
aiua-9216	29	55	from	from	ADP
aiua-9216	29	56	metastases	metastasis	NOUN
aiua-9216	29	57	of	of	ADP
aiua-9216	29	58	other	other	ADJ
aiua-9216	29	59	small	small	ADJ
aiua-9216	29	60	cell	cell	NOUN
aiua-9216	29	61	cancers	cancer	NOUN
aiua-9216	29	62	.	.	PUNCT
aiua-9216	30	1	therefore	therefore	ADV
aiua-9216	30	2	,	,	PUNCT
aiua-9216	30	3	in	in	ADP
aiua-9216	30	4	the	the	DET
aiua-9216	30	5	absence	absence	NOUN
aiua-9216	30	6	of	of	ADP
aiua-9216	30	7	a	a	DET
aiua-9216	30	8	primary	primary	ADJ
aiua-9216	30	9	scc	scc	NOUN
aiua-9216	30	10	at	at	ADP
aiua-9216	30	11	another	another	DET
aiua-9216	30	12	site	site	NOUN
aiua-9216	30	13	(	(	PUNCT
aiua-9216	30	14	for	for	ADP
aiua-9216	30	15	example	example	NOUN
aiua-9216	30	16	,	,	PUNCT
aiua-9216	30	17	the	the	DET
aiua-9216	30	18	lung	lung	NOUN
aiua-9216	30	19	)	)	PUNCT
aiua-9216	30	20	,	,	PUNCT
aiua-9216	30	21	the	the	DET
aiua-9216	30	22	finding	finding	NOUN
aiua-9216	30	23	of	of	ADP
aiua-9216	30	24	scc	scc	NOUN
aiua-9216	30	25	on	on	ADP
aiua-9216	30	26	prostate	prostate	NOUN
aiua-9216	30	27	biopsy	biopsy	NOUN
aiua-9216	30	28	is	be	AUX
aiua-9216	30	29	almost	almost	ADV
aiua-9216	30	30	undoubtedly	undoubtedly	ADV
aiua-9216	30	31	an	an	DET
aiua-9216	30	32	indication	indication	NOUN
aiua-9216	30	33	of	of	ADP
aiua-9216	30	34	prostatic	prostatic	ADJ
aiua-9216	30	35	origin	origin	NOUN
aiua-9216	30	36	.	.	PUNCT
aiua-9216	31	1	in	in	ADP
aiua-9216	31	2	the	the	DET
aiua-9216	31	3	last	last	ADJ
aiua-9216	31	4	years	year	NOUN
aiua-9216	31	5	,	,	PUNCT
aiua-9216	31	6	gene	gene	NOUN
aiua-9216	31	7	expression	expression	NOUN
aiua-9216	31	8	in	in	ADP
aiua-9216	31	9	metastatic	metastatic	ADJ
aiua-9216	31	10	crpc	crpc	ADJ
aiua-9216	31	11	neuroendocrine	neuroendocrine	ADJ
aiua-9216	31	12	scc	scc	NOUN
aiua-9216	31	13	prostate	prostate	NOUN
aiua-9216	31	14	has	have	AUX
aiua-9216	31	15	been	be	AUX
aiua-9216	31	16	tested	test	VERB
aiua-9216	31	17	confirming	confirm	VERB
aiua-9216	31	18	similar	similar	ADJ
aiua-9216	31	19	molecular	molecular	ADJ
aiua-9216	31	20	profile	profile	NOUN
aiua-9216	31	21	with	with	ADP
aiua-9216	31	22	small	small	ADJ
aiua-9216	31	23	cell	cell	NOUN
aiua-9216	31	24	lung	lung	NOUN
aiua-9216	31	25	carcinoma	carcinoma	NOUN
aiua-9216	31	26	(	(	PUNCT
aiua-9216	31	27	8)	8)	NUM
aiua-9216	31	28	.	.	PUNCT
aiua-9216	32	1	in	in	ADP
aiua-9216	32	2	addition	addition	NOUN
aiua-9216	32	3	,	,	PUNCT
aiua-9216	32	4	molecular	molecular	ADJ
aiua-9216	32	5	studies	study	NOUN
aiua-9216	32	6	have	have	AUX
aiua-9216	32	7	reported	report	VERB
aiua-9216	32	8	an	an	DET
aiua-9216	32	9	increased	increase	VERB
aiua-9216	32	10	expression	expression	NOUN
aiua-9216	32	11	of	of	ADP
aiua-9216	32	12	gene	gene	NOUN
aiua-9216	32	13	involved	involve	VERB
aiua-9216	32	14	in	in	ADP
aiua-9216	32	15	cellular	cellular	ADJ
aiua-9216	32	16	proliferation	proliferation	NOUN
aiua-9216	32	17	,	,	PUNCT
aiua-9216	32	18	cell	cell	NOUN
aiua-9216	32	19	cycle	cycle	NOUN
aiua-9216	32	20	,	,	PUNCT
aiua-9216	32	21	neuroendocrine	neuroendocrine	ADJ
aiua-9216	32	22	differentiation	differentiation	NOUN
aiua-9216	32	23	and	and	CCONJ
aiua-9216	32	24	mitosis	mitosis	NOUN
aiua-9216	32	25	.	.	PUNCT
aiua-9216	33	1	metzger	metzger	PROPN
aiua-9216	33	2	et	et	PROPN
aiua-9216	33	3	al	al	PROPN
aiua-9216	33	4	.	.	PROPN
aiua-9216	34	1	(	(	PUNCT
aiua-9216	34	2	5	5	X
aiua-9216	34	3	)	)	PUNCT
aiua-9216	34	4	reported	report	VERB
aiua-9216	34	5	on	on	ADP
aiua-9216	34	6	657	657	NUM
aiua-9216	34	7	men	man	NOUN
aiua-9216	34	8	with	with	ADP
aiua-9216	34	9	neuroendocrine	neuroendocrine	NOUN
aiua-9216	34	10	scc	scc	NOUN
aiua-9216	34	11	an	an	DET
aiua-9216	34	12	overall	overall	ADJ
aiua-9216	34	13	survival	survival	NOUN
aiua-9216	34	14	of	of	ADP
aiua-9216	34	15	12	12	NUM
aiua-9216	34	16	months	month	NOUN
aiua-9216	34	17	.	.	PUNCT
aiua-9216	35	1	wang	wang	PROPN
aiua-9216	35	2	et	et	PROPN
aiua-9216	35	3	al	al	PROPN
aiua-9216	35	4	.	.	PROPN
aiua-9216	36	1	(	(	PUNCT
aiua-9216	36	2	9	9	NUM
aiua-9216	36	3	)	)	PUNCT
aiua-9216	36	4	on	on	ADP
aiua-9216	36	5	260	260	NUM
aiua-9216	36	6	patients	patient	NOUN
aiua-9216	36	7	selected	select	VERB
aiua-9216	36	8	from	from	ADP
aiua-9216	36	9	surveillance	surveillance	NOUN
aiua-9216	36	10	,	,	PUNCT
aiua-9216	36	11	epidemiology	epidemiology	NOUN
aiua-9216	36	12	,	,	PUNCT
aiua-9216	36	13	and	and	CCONJ
aiua-9216	36	14	end	end	VERB
aiua-9216	36	15	results	result	NOUN
aiua-9216	36	16	(	(	PUNCT
aiua-9216	36	17	seer	seer	NOUN
aiua-9216	36	18	)	)	PUNCT
aiua-9216	36	19	database	database	NOUN
aiua-9216	36	20	showed	show	VERB
aiua-9216	36	21	an	an	DET
aiua-9216	36	22	increased	increase	VERB
aiua-9216	36	23	incidence	incidence	NOUN
aiua-9216	36	24	of	of	ADP
aiua-9216	36	25	prostate	prostate	NOUN
aiua-9216	36	26	scc	scc	NOUN
aiua-9216	36	27	over	over	ADP
aiua-9216	36	28	time	time	NOUN
aiua-9216	36	29	that	that	PRON
aiua-9216	36	30	was	be	AUX
aiua-9216	36	31	characterized	characterize	VERB
aiua-9216	36	32	by	by	ADP
aiua-9216	36	33	presence	presence	NOUN
aiua-9216	36	34	of	of	ADP
aiua-9216	36	35	high	high	ADJ
aiua-9216	36	36	stage	stage	NOUN
aiua-9216	36	37	(	(	PUNCT
aiua-9216	36	38	stage	stage	NOUN
aiua-9216	36	39	iv	iv	NUM
aiua-9216	36	40	in	in	ADP
aiua-9216	36	41	77.7	77.7	NUM
aiua-9216	36	42	%	%	NOUN
aiua-9216	36	43	)	)	PUNCT
aiua-9216	36	44	,	,	PUNCT
aiua-9216	36	45	nodes	nod	VERB
aiua-9216	36	46	involvement	involvement	NOUN
aiua-9216	36	47	(	(	PUNCT
aiua-9216	36	48	49	49	NUM
aiua-9216	36	49	%	%	NOUN
aiua-9216	36	50	)	)	PUNCT
aiua-9216	36	51	and	and	CCONJ
aiua-9216	36	52	distant	distant	ADJ
aiua-9216	36	53	metastases	metastasis	NOUN
aiua-9216	36	54	(	(	PUNCT
aiua-9216	36	55	68	68	NUM
aiua-9216	36	56	%	%	NOUN
aiua-9216	36	57	)	)	PUNCT
aiua-9216	36	58	with	with	ADP
aiua-9216	36	59	psa	psa	NOUN
aiua-9216	36	60	values	value	NOUN
aiua-9216	36	61	greater	great	ADJ
aiua-9216	36	62	than	than	ADP
aiua-9216	36	63	10	10	NUM
aiua-9216	36	64	ng	ng	NOUN
aiua-9216	36	65	/	/	SYM
aiua-9216	36	66	ml	ml	NOUN
aiua-9216	36	67	only	only	ADV
aiua-9216	36	68	in	in	ADP
aiua-9216	36	69	23	23	NUM
aiua-9216	36	70	%	%	NOUN
aiua-9216	36	71	of	of	ADP
aiua-9216	36	72	the	the	DET
aiua-9216	36	73	cases	case	NOUN
aiua-9216	36	74	;	;	PUNCT
aiua-9216	36	75	although	although	SCONJ
aiua-9216	36	76	patients	patient	NOUN
aiua-9216	36	77	underwent	undergo	VERB
aiua-9216	36	78	chemotherapy	chemotherapy	NOUN
aiua-9216	36	79	(	(	PUNCT
aiua-9216	36	80	58.8	58.8	NUM
aiua-9216	36	81	%	%	NOUN
aiua-9216	36	82	)	)	PUNCT
aiua-9216	36	83	,	,	PUNCT
aiua-9216	36	84	surgery	surgery	NOUN
aiua-9216	36	85	(	(	PUNCT
aiua-9216	36	86	25.4	25.4	NUM
aiua-9216	36	87	%	%	NOUN
aiua-9216	36	88	)	)	PUNCT
aiua-9216	36	89	and	and	CCONJ
aiua-9216	36	90	,	,	PUNCT
aiua-9216	36	91	radiotherapy	radiotherapy	NOUN
aiua-9216	36	92	(	(	PUNCT
aiua-9216	36	93	31.9	31.9	NUM
aiua-9216	36	94	%	%	NOUN
aiua-9216	36	95	)	)	PUNCT
aiua-9216	36	96	the	the	DET
aiua-9216	36	97	observed	observed	ADJ
aiua-9216	36	98	survival	survival	NOUN
aiua-9216	36	99	rates	rate	NOUN
aiua-9216	36	100	of	of	ADP
aiua-9216	36	101	1	1	NUM
aiua-9216	36	102	-	-	PUNCT
aiua-9216	36	103	year	year	NOUN
aiua-9216	36	104	,	,	PUNCT
aiua-9216	36	105	2	2	NUM
aiua-9216	36	106	-	-	PUNCT
aiua-9216	36	107	year	year	NOUN
aiua-9216	36	108	,	,	PUNCT
aiua-9216	36	109	and	and	CCONJ
aiua-9216	36	110	5	5	NUM
aiua-9216	36	111	-	-	PUNCT
aiua-9216	36	112	year	year	NOUN
aiua-9216	36	113	were	be	AUX
aiua-9216	36	114	42.1	42.1	NUM
aiua-9216	36	115	%	%	NOUN
aiua-9216	36	116	,	,	PUNCT
aiua-9216	36	117	22.1	22.1	NUM
aiua-9216	36	118	%	%	NOUN
aiua-9216	36	119	,	,	PUNCT
aiua-9216	36	120	and	and	CCONJ
aiua-9216	36	121	12.5	12.5	NUM
aiua-9216	36	122	%	%	NOUN
aiua-9216	36	123	,	,	PUNCT
aiua-9216	36	124	respectively	respectively	ADV
aiua-9216	36	125	.	.	PUNCT
aiua-9216	37	1	although	although	SCONJ
aiua-9216	37	2	the	the	DET
aiua-9216	37	3	poor	poor	ADJ
aiua-9216	37	4	prognosis	prognosis	NOUN
aiua-9216	37	5	,	,	PUNCT
aiua-9216	37	6	it	it	PRON
aiua-9216	37	7	is	be	AUX
aiua-9216	37	8	important	important	ADJ
aiua-9216	37	9	to	to	PART
aiua-9216	37	10	make	make	VERB
aiua-9216	37	11	distinction	distinction	NOUN
aiua-9216	37	12	between	between	ADP
aiua-9216	37	13	primitive	primitive	ADJ
aiua-9216	37	14	prostate	prostate	NOUN
aiua-9216	37	15	scc	scc	NOUN
aiua-9216	37	16	and	and	CCONJ
aiua-9216	37	17	ne	ne	ADJ
aiua-9216	37	18	-	-	NOUN
aiua-9216	37	19	crpc	crpc	ADV
aiua-9216	37	20	because	because	SCONJ
aiua-9216	37	21	therapeutic	therapeutic	ADJ
aiua-9216	37	22	strategy	strategy	NOUN
aiua-9216	37	23	changes	change	NOUN
aiua-9216	37	24	and	and	CCONJ
aiua-9216	37	25	should	should	AUX
aiua-9216	37	26	be	be	AUX
aiua-9216	37	27	managed	manage	VERB
aiua-9216	37	28	similarly	similarly	ADV
aiua-9216	37	29	to	to	ADP
aiua-9216	37	30	other	other	ADJ
aiua-9216	37	31	non	non	ADJ
aiua-9216	37	32	-	-	ADJ
aiua-9216	37	33	prostatic	prostatic	ADJ
aiua-9216	37	34	scc	scc	NOUN
aiua-9216	37	35	.	.	PUNCT
aiua-9216	38	1	rarely	rarely	ADV
aiua-9216	38	2	prostatectomy	prostatectomy	ADP
aiua-9216	38	3	or	or	CCONJ
aiua-9216	38	4	radiotherapy	radiotherapy	NOUN
aiua-9216	38	5	alone	alone	ADV
aiua-9216	38	6	have	have	AUX
aiua-9216	38	7	been	be	AUX
aiua-9216	38	8	shown	show	VERB
aiua-9216	38	9	to	to	PART
aiua-9216	38	10	be	be	AUX
aiua-9216	38	11	curative	curative	ADJ
aiua-9216	38	12	because	because	SCONJ
aiua-9216	38	13	the	the	DET
aiua-9216	38	14	tumor	tumor	NOUN
aiua-9216	38	15	,	,	PUNCT
aiua-9216	38	16	in	in	ADP
aiua-9216	38	17	the	the	DET
aiua-9216	38	18	majority	majority	NOUN
aiua-9216	38	19	of	of	ADP
aiua-9216	38	20	the	the	DET
aiua-9216	38	21	cases	case	NOUN
aiua-9216	38	22	,	,	PUNCT
aiua-9216	38	23	is	be	AUX
aiua-9216	38	24	metastatic	metastatic	ADJ
aiua-9216	38	25	(	(	PUNCT
aiua-9216	38	26	5	5	NUM
aiua-9216	38	27	)	)	PUNCT
aiua-9216	38	28	,	,	PUNCT
aiua-9216	38	29	moreover	moreover	ADV
aiua-9216	38	30	,	,	PUNCT
aiua-9216	38	31	prostate	prostate	NOUN
aiua-9216	38	32	scc	scc	PROPN
aiua-9216	38	33	is	be	AUX
aiua-9216	38	34	usually	usually	ADV
aiua-9216	38	35	not	not	PART
aiua-9216	38	36	responsive	responsive	ADJ
aiua-9216	38	37	to	to	ADP
aiua-9216	38	38	androgen	androgen	NOUN
aiua-9216	38	39	deprivation	deprivation	NOUN
aiua-9216	38	40	and	and	CCONJ
aiua-9216	38	41	disease	disease	NOUN
aiua-9216	38	42	progression	progression	NOUN
aiua-9216	38	43	is	be	AUX
aiua-9216	38	44	not	not	PART
aiua-9216	38	45	associated	associate	VERB
aiua-9216	38	46	with	with	ADP
aiua-9216	38	47	rises	rise	NOUN
aiua-9216	38	48	in	in	ADP
aiua-9216	38	49	serum	serum	NOUN
aiua-9216	38	50	psa	psa	NOUN
aiua-9216	38	51	values	value	NOUN
aiua-9216	38	52	.	.	PUNCT
aiua-9216	39	1	in	in	ADP
aiua-9216	39	2	definitive	definitive	ADJ
aiua-9216	39	3	,	,	PUNCT
aiua-9216	39	4	the	the	DET
aiua-9216	39	5	best	good	ADJ
aiua-9216	39	6	treatment	treatment	NOUN
aiua-9216	39	7	remains	remain	VERB
aiua-9216	39	8	the	the	DET
aiua-9216	39	9	multidisciplinary	multidisciplinary	ADJ
aiua-9216	39	10	approach	approach	NOUN
aiua-9216	39	11	by	by	ADP
aiua-9216	39	12	chemotherapy	chemotherapy	NOUN
aiua-9216	39	13	alone	alone	ADV
aiua-9216	39	14	or	or	CCONJ
aiua-9216	39	15	combined	combine	VERB
aiua-9216	39	16	with	with	ADP
aiua-9216	39	17	local	local	ADJ
aiua-9216	39	18	therapy	therapy	NOUN
aiua-9216	39	19	that	that	PRON
aiua-9216	39	20	could	could	AUX
aiua-9216	39	21	offer	offer	VERB
aiua-9216	39	22	local	local	ADJ
aiua-9216	39	23	palliation	palliation	NOUN
aiua-9216	39	24	of	of	ADP
aiua-9216	39	25	clinical	clinical	ADJ
aiua-9216	39	26	symptoms	symptom	NOUN
aiua-9216	39	27	(	(	PUNCT
aiua-9216	39	28	5	5	NUM
aiua-9216	39	29	,	,	PUNCT
aiua-9216	39	30	10	10	NUM
aiua-9216	39	31	)	)	PUNCT
aiua-9216	39	32	.	.	PUNCT
aiua-9216	40	1	in	in	ADP
aiua-9216	40	2	our	our	PRON
aiua-9216	40	3	case	case	NOUN
aiua-9216	40	4	,	,	PUNCT
aiua-9216	40	5	the	the	DET
aiua-9216	40	6	patient	patient	NOUN
aiua-9216	40	7	had	have	VERB
aiua-9216	40	8	a	a	DET
aiua-9216	40	9	primitive	primitive	ADJ
aiua-9216	40	10	prostate	prostate	NOUN
aiua-9216	40	11	scc	scc	NOUN
aiua-9216	40	12	characterized	characterize	VERB
aiua-9216	40	13	as	as	ADP
aiua-9216	40	14	locally	locally	ADV
aiua-9216	40	15	advanced	advanced	ADJ
aiua-9216	40	16	cancer	cancer	NOUN
aiua-9216	40	17	involving	involve	VERB
aiua-9216	40	18	bladder	bladder	NOUN
aiua-9216	40	19	and	and	CCONJ
aiua-9216	40	20	kidney	kidney	NOUN
aiua-9216	40	21	function	function	NOUN
aiua-9216	40	22	in	in	ADP
aiua-9216	40	23	absence	absence	NOUN
aiua-9216	40	24	of	of	ADP
aiua-9216	40	25	documented	document	VERB
aiua-9216	40	26	distant	distant	ADJ
aiua-9216	40	27	metastases	metastasis	NOUN
aiua-9216	40	28	;	;	PUNCT
aiua-9216	40	29	therefore	therefore	ADV
aiua-9216	40	30	,	,	PUNCT
aiua-9216	40	31	we	we	PRON
aiua-9216	40	32	do	do	AUX
aiua-9216	40	33	n’t	not	PART
aiua-9216	40	34	know	know	VERB
aiua-9216	40	35	if	if	SCONJ
aiua-9216	40	36	the	the	DET
aiua-9216	40	37	patient	patient	NOUN
aiua-9216	40	38	died	die	VERB
aiua-9216	40	39	from	from	ADP
aiua-9216	40	40	prostate	prostate	NOUN
aiua-9216	40	41	scc	scc	NOUN
aiua-9216	40	42	or	or	CCONJ
aiua-9216	40	43	from	from	ADP
aiua-9216	40	44	concomitant	concomitant	ADJ
aiua-9216	40	45	onset	onset	VERB
aiua-9216	40	46	systemic	systemic	ADJ
aiua-9216	40	47	pathologies	pathology	NOUN
aiua-9216	40	48	.	.	PUNCT
aiua-9216	41	1	in	in	ADP
aiua-9216	41	2	conclusion	conclusion	NOUN
aiua-9216	41	3	,	,	PUNCT
aiua-9216	41	4	although	although	SCONJ
aiua-9216	41	5	prostate	prostate	NOUN
aiua-9216	41	6	scc	scc	NOUN
aiua-9216	41	7	could	could	AUX
aiua-9216	41	8	be	be	AUX
aiua-9216	41	9	suspected	suspect	VERB
aiua-9216	41	10	in	in	ADP
aiua-9216	41	11	men	man	NOUN
aiua-9216	41	12	with	with	ADP
aiua-9216	41	13	crpc	crpc	ADJ
aiua-9216	41	14	with	with	ADP
aiua-9216	41	15	clinical	clinical	ADJ
aiua-9216	41	16	progression	progression	NOUN
aiua-9216	41	17	,	,	PUNCT
aiua-9216	41	18	primitive	primitive	ADJ
aiua-9216	41	19	scc	scc	NOUN
aiua-9216	41	20	represents	represent	VERB
aiua-9216	41	21	a	a	DET
aiua-9216	41	22	very	very	ADV
aiua-9216	41	23	rare	rare	ADJ
aiua-9216	41	24	cancer	cancer	NOUN
aiua-9216	41	25	provided	provide	VERB
aiua-9216	41	26	of	of	ADP
aiua-9216	41	27	poor	poor	ADJ
aiua-9216	41	28	prognosis	prognosis	NOUN
aiua-9216	41	29	and	and	CCONJ
aiua-9216	41	30	only	only	ADV
aiua-9216	41	31	prostate	prostate	NOUN
aiua-9216	41	32	biopsy	biopsy	NOUN
aiua-9216	41	33	combined	combine	VERB
aiua-9216	41	34	with	with	ADP
aiua-9216	41	35	an	an	DET
aiua-9216	41	36	accurate	accurate	ADJ
aiua-9216	41	37	specimen	speciman	NOUN
aiua-9216	41	38	analysis	analysis	NOUN
aiua-9216	41	39	allow	allow	VERB
aiua-9216	41	40	to	to	PART
aiua-9216	41	41	make	make	VERB
aiua-9216	41	42	the	the	DET
aiua-9216	41	43	correct	correct	ADJ
aiua-9216	41	44	diagnosis	diagnosis	NOUN
aiua-9216	41	45	and	and	CCONJ
aiua-9216	41	46	therapeutic	therapeutic	ADJ
aiua-9216	41	47	treatment	treatment	NOUN
aiua-9216	41	48	.	.	PUNCT
aiua-9216	42	1	references	reference	NOUN
aiua-9216	42	2	1	1	NUM
aiua-9216	42	3	.	.	PUNCT
aiua-9216	43	1	terada	terada	PROPN
aiua-9216	43	2	t.	t.	PROPN
aiua-9216	43	3	small	small	ADJ
aiua-9216	43	4	cell	cell	NOUN
aiua-9216	43	5	neuroendocrine	neuroendocrine	NOUN
aiua-9216	43	6	carcinoma	carcinoma	NOUN
aiua-9216	43	7	of	of	ADP
aiua-9216	43	8	the	the	DET
aiua-9216	43	9	prostate	prostate	NOUN
aiua-9216	43	10	:	:	PUNCT
aiua-9216	43	11	incidence	incidence	NOUN
aiua-9216	43	12	and	and	CCONJ
aiua-9216	43	13	a	a	DET
aiua-9216	43	14	report	report	NOUN
aiua-9216	43	15	of	of	ADP
aiua-9216	43	16	four	four	NUM
aiua-9216	43	17	cases	case	NOUN
aiua-9216	43	18	with	with	ADP
aiua-9216	43	19	an	an	DET
aiua-9216	43	20	examination	examination	NOUN
aiua-9216	43	21	of	of	ADP
aiua-9216	43	22	kit	kit	NOUN
aiua-9216	43	23	and	and	CCONJ
aiua-9216	43	24	pdgfra	pdgfra	NOUN
aiua-9216	43	25	.	.	PUNCT
aiua-9216	44	1	prostate	prostate	NOUN
aiua-9216	44	2	.	.	PUNCT
aiua-9216	45	1	2012	2012	NUM
aiua-9216	45	2	;	;	PUNCT
aiua-9216	45	3	72:1150	72:1150	NUM
aiua-9216	45	4	-	-	SYM
aiua-9216	45	5	1156	1156	NUM
aiua-9216	45	6	.	.	PUNCT
aiua-9216	46	1	2	2	X
aiua-9216	46	2	.	.	X
aiua-9216	46	3	wang	wang	PROPN
aiua-9216	46	4	w	w	PROPN
aiua-9216	46	5	,	,	PUNCT
aiua-9216	46	6	epstein	epstein	PROPN
aiua-9216	46	7	ji	ji	PROPN
aiua-9216	46	8	.	.	PROPN
aiua-9216	46	9	small	small	ADJ
aiua-9216	46	10	cell	cell	NOUN
aiua-9216	46	11	carcinoma	carcinoma	NOUN
aiua-9216	46	12	of	of	ADP
aiua-9216	46	13	the	the	DET
aiua-9216	46	14	prostate	prostate	NOUN
aiua-9216	46	15	.	.	PUNCT
aiua-9216	47	1	a	a	DET
aiua-9216	47	2	morphologic	morphologic	ADJ
aiua-9216	47	3	and	and	CCONJ
aiua-9216	47	4	immunohistocemical	immunohistocemical	ADJ
aiua-9216	47	5	study	study	NOUN
aiua-9216	47	6	of	of	ADP
aiua-9216	47	7	95	95	NUM
aiua-9216	47	8	cases	case	NOUN
aiua-9216	47	9	.	.	PUNCT
aiua-9216	48	1	am	be	AUX
aiua-9216	48	2	j	j	PROPN
aiua-9216	48	3	surg	surg	PROPN
aiua-9216	48	4	pathol	pathol	NOUN
aiua-9216	48	5	.	.	PUNCT
aiua-9216	49	1	2008	2008	NUM
aiua-9216	49	2	;	;	PUNCT
aiua-9216	49	3	32:65	32:65	NUM
aiua-9216	49	4	-	-	SYM
aiua-9216	49	5	71	71	NUM
aiua-9216	49	6	.	.	PUNCT
aiua-9216	50	1	3	3	X
aiua-9216	50	2	.	.	X
aiua-9216	50	3	wenk	wenk	PROPN
aiua-9216	50	4	re	re	PROPN
aiua-9216	50	5	,	,	PUNCT
aiua-9216	50	6	bhagavan	bhagavan	PROPN
aiua-9216	50	7	bs	bs	PROPN
aiua-9216	50	8	,	,	PUNCT
aiua-9216	50	9	levy	levy	NOUN
aiua-9216	50	10	r	r	NOUN
aiua-9216	50	11	,	,	PUNCT
aiua-9216	50	12	et	et	PROPN
aiua-9216	50	13	al	al	PROPN
aiua-9216	50	14	.	.	PROPN
aiua-9216	50	15	ectopic	ectopic	PROPN
aiua-9216	50	16	acth	acth	NOUN
aiua-9216	50	17	,	,	PUNCT
aiua-9216	50	18	prostatic	prostatic	ADJ
aiua-9216	50	19	oat	oat	NOUN
aiua-9216	50	20	cell	cell	NOUN
aiua-9216	50	21	carcinoma	carcinoma	NOUN
aiua-9216	50	22	,	,	PUNCT
aiua-9216	50	23	and	and	CCONJ
aiua-9216	50	24	marked	mark	VERB
aiua-9216	50	25	hypernatremia	hypernatremia	NOUN
aiua-9216	50	26	.	.	PUNCT
aiua-9216	51	1	cancer	cancer	NOUN
aiua-9216	51	2	.	.	PUNCT
aiua-9216	52	1	1977	1977	NUM
aiua-9216	52	2	;	;	PUNCT
aiua-9216	52	3	40:773	40:773	NUM
aiua-9216	52	4	-	-	SYM
aiua-9216	52	5	778	778	NUM
aiua-9216	52	6	.	.	PUNCT
aiua-9216	53	1	4	4	NUM
aiua-9216	53	2	.	.	X
aiua-9216	54	1	zhang	zhang	PROPN
aiua-9216	54	2	y	y	PROPN
aiua-9216	54	3	,	,	PUNCT
aiua-9216	54	4	ouyang	ouyang	PROPN
aiua-9216	54	5	w	w	PROPN
aiua-9216	54	6	,	,	PUNCT
aiua-9216	54	7	sun	sun	NOUN
aiua-9216	54	8	g	g	NOUN
aiua-9216	54	9	,	,	PUNCT
aiua-9216	54	10	et	et	PROPN
aiua-9216	54	11	al	al	PROPN
aiua-9216	54	12	.	.	PUNCT
aiua-9216	55	1	pure	pure	ADJ
aiua-9216	55	2	small	small	ADJ
aiua-9216	55	3	cell	cell	NOUN
aiua-9216	55	4	carcinoma	carcinoma	NOUN
aiua-9216	55	5	of	of	ADP
aiua-9216	55	6	prostate	prostate	NOUN
aiua-9216	55	7	:	:	PUNCT
aiua-9216	55	8	a	a	DET
aiua-9216	55	9	report	report	NOUN
aiua-9216	55	10	of	of	ADP
aiua-9216	55	11	8	8	NUM
aiua-9216	55	12	cases	case	NOUN
aiua-9216	55	13	.	.	PUNCT
aiua-9216	56	1	urol	urol	PROPN
aiua-9216	56	2	int	int	PROPN
aiua-9216	56	3	.	.	PUNCT
aiua-9216	57	1	2018	2018	NUM
aiua-9216	58	1	;	;	PUNCT
aiua-9216	58	2	101:263	101:263	PROPN
aiua-9216	58	3	-	-	PUNCT
aiua-9216	58	4	268	268	NUM
aiua-9216	58	5	.	.	PUNCT
aiua-9216	59	1	5	5	NUM
aiua-9216	59	2	.	.	X
aiua-9216	59	3	metzger	metzger	PROPN
aiua-9216	59	4	al	al	PROPN
aiua-9216	59	5	,	,	PUNCT
aiua-9216	59	6	abel	abel	PROPN
aiua-9216	59	7	s	s	PROPN
aiua-9216	59	8	,	,	PUNCT
aiua-9216	59	9	wegner	wegner	PROPN
aiua-9216	59	10	re	re	PROPN
aiua-9216	59	11	,	,	PUNCT
aiua-9216	59	12	et	et	PROPN
aiua-9216	59	13	al	al	PROPN
aiua-9216	59	14	.	.	PUNCT
aiua-9216	59	15	patterns	pattern	NOUN
aiua-9216	59	16	of	of	ADP
aiua-9216	59	17	care	care	NOUN
aiua-9216	59	18	and	and	CCONJ
aiua-9216	59	19	outcomes	outcome	NOUN
aiua-9216	59	20	in	in	ADP
aiua-9216	59	21	small	small	ADJ
aiua-9216	59	22	cell	cell	NOUN
aiua-9216	59	23	carcinoma	carcinoma	NOUN
aiua-9216	59	24	of	of	ADP
aiua-9216	59	25	the	the	DET
aiua-9216	59	26	prostate	prostate	NOUN
aiua-9216	59	27	:	:	PUNCT
aiua-9216	59	28	a	a	DET
aiua-9216	59	29	national	national	ADJ
aiua-9216	59	30	cancer	cancer	NOUN
aiua-9216	59	31	database	database	NOUN
aiua-9216	59	32	analysis	analysis	NOUN
aiua-9216	59	33	.	.	PUNCT
aiua-9216	60	1	prostate	prostate	NOUN
aiua-9216	60	2	2019	2019	NUM
aiua-9216	60	3	;	;	PUNCT
aiua-9216	60	4	79:1457	79:1457	NUM
aiua-9216	60	5	-	-	SYM
aiua-9216	60	6	1461	1461	NUM
aiua-9216	60	7	.	.	PUNCT
aiua-9216	61	1	6	6	NUM
aiua-9216	61	2	.	.	X
aiua-9216	61	3	pepe	pepe	PROPN
aiua-9216	61	4	p	p	NOUN
aiua-9216	61	5	,	,	PUNCT
aiua-9216	61	6	garufi	garufi	ADJ
aiua-9216	61	7	a	a	PRON
aiua-9216	61	8	,	,	PUNCT
aiua-9216	61	9	priolo	priolo	ADJ
aiua-9216	61	10	gd	gd	NOUN
aiua-9216	61	11	,	,	PUNCT
aiua-9216	61	12	et	et	PROPN
aiua-9216	61	13	al	al	PROPN
aiua-9216	61	14	.	.	PROPN
aiua-9216	61	15	is	be	AUX
aiua-9216	61	16	it	it	PRON
aiua-9216	61	17	time	time	NOUN
aiua-9216	61	18	to	to	PART
aiua-9216	61	19	perform	perform	VERB
aiua-9216	61	20	only	only	ADV
aiua-9216	61	21	magnetic	magnetic	ADJ
aiua-9216	61	22	resonance	resonance	NOUN
aiua-9216	61	23	imaging	image	VERB
aiua-9216	61	24	targeted	target	VERB
aiua-9216	61	25	cores	core	NOUN
aiua-9216	61	26	?	?	PUNCT
aiua-9216	62	1	our	our	PRON
aiua-9216	62	2	experience	experience	NOUN
aiua-9216	62	3	with	with	ADP
aiua-9216	62	4	1,032	1,032	NUM
aiua-9216	62	5	men	man	NOUN
aiua-9216	62	6	who	who	PRON
aiua-9216	62	7	underwent	undergo	VERB
aiua-9216	62	8	prostate	prostate	NOUN
aiua-9216	62	9	biopsy	biopsy	NOUN
aiua-9216	62	10	.	.	PUNCT
aiua-9216	63	1	j	j	PROPN
aiua-9216	63	2	urol	urol	PROPN
aiua-9216	63	3	.	.	PROPN
aiua-9216	63	4	2018	2018	NUM
aiua-9216	63	5	;	;	PUNCT
aiua-9216	63	6	200:774	200:774	NOUN
aiua-9216	63	7	-	-	PUNCT
aiua-9216	63	8	778	778	NUM
aiua-9216	63	9	.	.	PUNCT
aiua-9216	64	1	7	7	X
aiua-9216	64	2	.	.	X
aiua-9216	64	3	pepe	pepe	PROPN
aiua-9216	64	4	p	p	PROPN
aiua-9216	64	5	,	,	PUNCT
aiua-9216	64	6	fraggetta	fraggetta	PROPN
aiua-9216	64	7	f	f	PROPN
aiua-9216	64	8	,	,	PUNCT
aiua-9216	64	9	candiano	candiano	VERB
aiua-9216	64	10	g	g	PROPN
aiua-9216	64	11	,	,	PUNCT
aiua-9216	64	12	aragona	aragona	PROPN
aiua-9216	64	13	f.	f.	PROPN
aiua-9216	64	14	does	do	AUX
aiua-9216	64	15	ki-67	ki-67	NOUN
aiua-9216	64	16	staining	stain	VERB
aiua-9216	64	17	improve	improve	VERB
aiua-9216	64	18	quantitative	quantitative	ADJ
aiua-9216	64	19	histology	histology	NOUN
aiua-9216	64	20	in	in	ADP
aiua-9216	64	21	preoperative	preoperative	ADJ
aiua-9216	64	22	prostate	prostate	NOUN
aiua-9216	64	23	cancer	cancer	NOUN
aiua-9216	64	24	staging	staging	NOUN
aiua-9216	64	25	?	?	PUNCT
aiua-9216	65	1	arch	arch	ADJ
aiua-9216	65	2	ital	ital	PROPN
aiua-9216	65	3	urol	urol	PROPN
aiua-9216	65	4	androl	androl	PROPN
aiua-9216	65	5	.	.	PROPN
aiua-9216	65	6	2012	2012	NUM
aiua-9216	65	7	;	;	PUNCT
aiua-9216	65	8	84:32	84:32	NUM
aiua-9216	65	9	-	-	SYM
aiua-9216	65	10	35	35	NUM
aiua-9216	65	11	.	.	NOUN
aiua-9216	65	12	8	8	NUM
aiua-9216	65	13	.	.	X
aiua-9216	66	1	salemi	salemi	PROPN
aiua-9216	66	2	m	m	PROPN
aiua-9216	66	3	,	,	PUNCT
aiua-9216	66	4	galia	galia	PROPN
aiua-9216	66	5	a	a	PRON
aiua-9216	66	6	,	,	PUNCT
aiua-9216	66	7	fraggetta	fraggetta	ADJ
aiua-9216	66	8	f	f	NOUN
aiua-9216	66	9	,	,	PUNCT
aiua-9216	66	10	et	et	PROPN
aiua-9216	66	11	al	al	PROPN
aiua-9216	66	12	.	.	PROPN
aiua-9216	66	13	poly	poly	PROPN
aiua-9216	66	14	(	(	PUNCT
aiua-9216	66	15	adp	adp	PROPN
aiua-9216	66	16	-	-	PUNCT
aiua-9216	66	17	ribose	ribose	NOUN
aiua-9216	66	18	)	)	PUNCT
aiua-9216	66	19	polymerase	polymerase	NOUN
aiua-9216	66	20	1	1	NUM
aiua-9216	66	21	protein	protein	NOUN
aiua-9216	66	22	expression	expression	NOUN
aiua-9216	66	23	in	in	ADP
aiua-9216	66	24	normal	normal	ADJ
aiua-9216	66	25	and	and	CCONJ
aiua-9216	66	26	neoplastic	neoplastic	ADJ
aiua-9216	66	27	prostatic	prostatic	ADJ
aiua-9216	66	28	tissue	tissue	NOUN
aiua-9216	66	29	.	.	PUNCT
aiua-9216	67	1	eur	eur	PROPN
aiua-9216	67	2	j	j	PROPN
aiua-9216	67	3	histochem	histochem	PROPN
aiua-9216	67	4	.	.	PUNCT
aiua-9216	68	1	2013	2013	NUM
aiua-9216	68	2	;	;	PUNCT
aiua-9216	68	3	57	57	NUM
aiua-9216	68	4	:	:	PUNCT
aiua-9216	68	5	e13	e13	VERB
aiua-9216	68	6	.	.	PUNCT
aiua-9216	69	1	9	9	X
aiua-9216	69	2	.	.	X
aiua-9216	69	3	wang	wang	PROPN
aiua-9216	69	4	j	j	PROPN
aiua-9216	69	5	,	,	PUNCT
aiua-9216	69	6	liu	liu	PROPN
aiua-9216	69	7	x	x	PROPN
aiua-9216	69	8	,	,	PUNCT
aiua-9216	69	9	wang	wang	PROPN
aiua-9216	69	10	y	y	PROPN
aiua-9216	69	11	,	,	PUNCT
aiua-9216	69	12	ren	ren	PROPN
aiua-9216	69	13	g.	g.	PROPN
aiua-9216	69	14	current	current	ADJ
aiua-9216	69	15	trend	trend	NOUN
aiua-9216	69	16	of	of	ADP
aiua-9216	69	17	worsening	worsen	VERB
aiua-9216	69	18	prognosis	prognosis	NOUN
aiua-9216	69	19	of	of	ADP
aiua-9216	69	20	prostate	prostate	NOUN
aiua-9216	69	21	small	small	ADJ
aiua-9216	69	22	cell	cell	NOUN
aiua-9216	69	23	carcinoma	carcinoma	NOUN
aiua-9216	69	24	:	:	PUNCT
aiua-9216	69	25	a	a	DET
aiua-9216	69	26	population	population	NOUN
aiua-9216	69	27	-	-	PUNCT
aiua-9216	69	28	based	base	VERB
aiua-9216	69	29	study	study	NOUN
aiua-9216	69	30	.	.	PUNCT
aiua-9216	70	1	cancer	cancer	NOUN
aiua-9216	70	2	med	med	PROPN
aiua-9216	70	3	.	.	PROPN
aiua-9216	70	4	2019	2019	NUM
aiua-9216	70	5	;	;	PUNCT
aiua-9216	70	6	8	8	NUM
aiua-9216	70	7	:	:	SYM
aiua-9216	70	8	6799	6799	NUM
aiua-9216	70	9	-	-	SYM
aiua-9216	70	10	6806	6806	NUM
aiua-9216	70	11	.	.	PUNCT
aiua-9216	71	1	10	10	NUM
aiua-9216	71	2	.	.	X
aiua-9216	71	3	papandreou	papandreou	PROPN
aiua-9216	71	4	cn	cn	PROPN
aiua-9216	71	5	,	,	PUNCT
aiua-9216	71	6	daliani	daliani	PROPN
aiua-9216	71	7	dd	dd	PROPN
aiua-9216	71	8	,	,	PUNCT
aiua-9216	71	9	thall	thall	PROPN
aiua-9216	71	10	pf	pf	PROPN
aiua-9216	71	11	,	,	PUNCT
aiua-9216	71	12	et	et	PROPN
aiua-9216	71	13	al	al	PROPN
aiua-9216	71	14	.	.	PROPN
aiua-9216	71	15	results	result	NOUN
aiua-9216	71	16	of	of	ADP
aiua-9216	71	17	a	a	DET
aiua-9216	71	18	phase	phase	NOUN
aiua-9216	71	19	ii	ii	NOUN
aiua-9216	71	20	study	study	NOUN
aiua-9216	71	21	with	with	ADP
aiua-9216	71	22	doxorubicin	doxorubicin	PROPN
aiua-9216	71	23	,	,	PUNCT
aiua-9216	71	24	etoposide	etoposide	NOUN
aiua-9216	71	25	,	,	PUNCT
aiua-9216	71	26	and	and	CCONJ
aiua-9216	71	27	cisplatin	cisplatin	NOUN
aiua-9216	71	28	in	in	ADP
aiua-9216	71	29	patients	patient	NOUN
aiua-9216	71	30	with	with	ADP
aiua-9216	71	31	fully	fully	ADV
aiua-9216	71	32	characterized	characterize	VERB
aiua-9216	71	33	small	small	ADJ
aiua-9216	71	34	-	-	PUNCT
aiua-9216	71	35	cell	cell	NOUN
aiua-9216	71	36	carcinoma	carcinoma	NOUN
aiua-9216	71	37	of	of	ADP
aiua-9216	71	38	the	the	DET
aiua-9216	71	39	prostate	prostate	NOUN
aiua-9216	71	40	.	.	PUNCT
aiua-9216	72	1	j	j	PROPN
aiua-9216	72	2	clin	clin	PROPN
aiua-9216	72	3	oncol	oncol	PROPN
aiua-9216	72	4	.	.	PUNCT
aiua-9216	73	1	2002	2002	NUM
aiua-9216	73	2	;	;	PUNCT
aiua-9216	73	3	20:3072	20:3072	NOUN
aiua-9216	73	4	-	-	SYM
aiua-9216	73	5	3080	3080	NUM
aiua-9216	73	6	.	.	PUNCT
aiua-9216	74	1	figure	figure	NOUN
aiua-9216	74	2	1	1	NUM
aiua-9216	74	3	.	.	PUNCT
aiua-9216	75	1	tumour	tumour	NOUN
aiua-9216	75	2	was	be	AUX
aiua-9216	75	3	composed	compose	VERB
aiua-9216	75	4	of	of	ADP
aiua-9216	75	5	undifferentiated	undifferentiated	ADJ
aiua-9216	75	6	cells	cell	NOUN
aiua-9216	75	7	with	with	ADP
aiua-9216	75	8	scant	scant	ADJ
aiua-9216	75	9	cytoplasm	cytoplasm	NOUN
aiua-9216	75	10	,	,	PUNCT
aiua-9216	75	11	infiltrating	infiltrating	ADJ
aiua-9216	75	12	fatty	fatty	NOUN
aiua-9216	75	13	tissue	tissue	NOUN
aiua-9216	75	14	.	.	PUNCT
aiua-9216	76	1	figure	figure	NOUN
aiua-9216	76	2	2	2	NUM
aiua-9216	76	3	.	.	PUNCT
aiua-9216	77	1	neoplastic	neoplastic	ADJ
aiua-9216	77	2	cells	cell	NOUN
aiua-9216	77	3	showed	show	VERB
aiua-9216	77	4	a	a	DET
aiua-9216	77	5	high	high	ADJ
aiua-9216	77	6	proliferative	proliferative	ADJ
aiua-9216	77	7	fraction	fraction	NOUN
aiua-9216	77	8	as	as	SCONJ
aiua-9216	77	9	highlighted	highlight	VERB
aiua-9216	77	10	by	by	ADP
aiua-9216	77	11	ki67	ki67	PROPN
aiua-9216	77	12	.	.	PUNCT
aiua-9216	78	1	correspondence	correspondence	NOUN
aiua-9216	78	2	pietro	pietro	PROPN
aiua-9216	78	3	pepe	pepe	PROPN
aiua-9216	78	4	,	,	PUNCT
aiua-9216	78	5	md	md	PROPN
aiua-9216	78	6	(	(	PUNCT
aiua-9216	78	7	corresponding	correspond	VERB
aiua-9216	78	8	author	author	NOUN
aiua-9216	78	9	)	)	PUNCT
aiua-9216	79	1	piepepe@hotmail.com	piepepe@hotmail.com	X
aiua-9216	80	1	michele	michele	PROPN
aiua-9216	80	2	pennisi	pennisi	VERB
aiua-9216	80	3	,	,	PUNCT
aiua-9216	80	4	md	md	PROPN
aiua-9216	80	5	ludovica	ludovica	PROPN
aiua-9216	80	6	pepe	pepe	PROPN
aiua-9216	80	7	urology	urology	PROPN
aiua-9216	80	8	unit	unit	NOUN
aiua-9216	80	9	cannizzaro	cannizzaro	NOUN
aiua-9216	80	10	hospital	hospital	PROPN
aiua-9216	80	11	,	,	PUNCT
aiua-9216	80	12	catania	catania	PROPN
aiua-9216	80	13	via	via	ADP
aiua-9216	80	14	messina	messina	PROPN
aiua-9216	80	15	829	829	NUM
aiua-9216	80	16	,	,	PUNCT
aiua-9216	80	17	catania	catania	PROPN
aiua-9216	80	18	(	(	PUNCT
aiua-9216	80	19	italy	italy	PROPN
aiua-9216	80	20	)	)	PUNCT
aiua-9216	80	21	mara	mara	PROPN
aiua-9216	80	22	curdman	curdman	PROPN
aiua-9216	80	23	,	,	PUNCT
aiua-9216	80	24	md	md	PROPN
aiua-9216	80	25	filippo	filippo	PROPN
aiua-9216	80	26	fraggetta	fraggetta	PROPN
aiua-9216	80	27	,	,	PUNCT
aiua-9216	80	28	md	md	PROPN
aiua-9216	80	29	pathology	pathology	PROPN
aiua-9216	80	30	unit	unit	NOUN
aiua-9216	80	31	cannizzaro	cannizzaro	NOUN
aiua-9216	80	32	hospital	hospital	PROPN
aiua-9216	80	33	,	,	PUNCT
aiua-9216	80	34	catania	catania	PROPN
aiua-9216	80	35	(	(	PUNCT
aiua-9216	80	36	italy	italy	PROPN
aiua-9216	80	37	)	)	PUNCT